[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$apiParty6fBuHLCPZ1LTYs42XHdVbjpSDOYYPYzyxeAGwSN5Tp8":3,"$apiPartyogXLjUaaAqf7aS2cgc-Ursgw-XyZY42h0dkNRlxGoBA":563,"$apiPartyogXLjUaaAqf7aS2cgc-Ursgw-XyZY42h0dkNRlxGoBA$H93EERW16b":563},{"product_data":4,"scene_data":21,"task_data":407,"modality_data":441,"domain_data":478},[5,9,12,15,18],{"name":6,"value":7,"add_value":8,"describe":8},"Rivo","1","",{"name":10,"value":11,"add_value":8,"describe":8},"Cubo","2",{"name":13,"value":14,"add_value":8,"describe":8},"Moye","3",{"name":16,"value":17,"add_value":8,"describe":8},"Juro","4",{"name":19,"value":20,"add_value":8,"describe":8},"Ordo","5",[22,73,135,197,232,267,302,337,372],{"name":23,"value":7,"add_value":24,"describe":25,"children":26},"Home & Indoor","sofa","AI enhances everyday home life. Our datasets cover real indoor scenes to support smart devices, robotics, and home intelligence.",[27,29,31,33,35,37,40,43,46,49,52,55,58,61,64,67,70],{"name":28,"value":7},"Living Room",{"name":30,"value":11},"Bedroom",{"name":32,"value":14},"Kitchen",{"name":34,"value":17},"Dining Area",{"name":36,"value":20},"Bathroom",{"name":38,"value":39},"Entrance \u002F Foyer","6",{"name":41,"value":42},"Corridor \u002F Hallway","7",{"name":44,"value":45},"Staircase","8",{"name":47,"value":48},"Home Office","9",{"name":50,"value":51},"Hobby \u002F Game Room","10",{"name":53,"value":54},"Worship Space","11",{"name":56,"value":57},"Garage","12",{"name":59,"value":60},"Utility \u002F Laundry Room","13",{"name":62,"value":63},"Pantry","14",{"name":65,"value":66},"Basement","15",{"name":68,"value":69},"Garden","16",{"name":71,"value":72},"Balcony","17",{"name":74,"value":11,"add_value":75,"describe":76,"children":77},"Office & Educational","workshop","AI is reshaping work and learning. Our datasets capture offices and classrooms to power automation and next-generation productivity tools.",[78,81,84,87,90,93,96,99,102,105,108,111,114,117,120,123,126,129,132],{"name":79,"value":80},"Open Office","18",{"name":82,"value":83},"Private Office","19",{"name":85,"value":86},"Co-working Space","20",{"name":88,"value":89},"Reception \u002F Lobby","21",{"name":91,"value":92},"Conference Room","22",{"name":94,"value":95},"Huddle Room \u002F Booth","23",{"name":97,"value":98},"Lecture Hall \u002F Auditorium","24",{"name":100,"value":101},"Classroom","25",{"name":103,"value":104},"Science Laboratory","26",{"name":106,"value":107},"Library","27",{"name":109,"value":110},"Design Studio","28",{"name":112,"value":113},"Pantry \u002F Breakroom","29",{"name":115,"value":116},"Cafeteria \u002F Canteen","30",{"name":118,"value":119},"Restroom (Commercial)","31",{"name":121,"value":122},"Gymnasium \u002F Sports Hall","32",{"name":124,"value":125},"Server Room","33",{"name":127,"value":128},"Mailroom \u002F Logistics","34",{"name":130,"value":131},"Janitorial Closet","35",{"name":133,"value":134},"Corridor \u002F Elevators","36",{"name":136,"value":14,"add_value":137,"describe":138,"children":139},"Healthcare & Medical","love-and-help","AI is advancing modern healthcare. Our datasets include clinics and hospitals to enable clinical insights and medical automation.",[140,143,146,149,152,155,158,161,164,167,170,173,176,179,182,185,188,191,194],{"name":141,"value":142},"Operating Theatre \u002F OR","37",{"name":144,"value":145},"Consultation Room","38",{"name":147,"value":148},"Treatment Room","39",{"name":150,"value":151},"Dental Clinic","40",{"name":153,"value":154},"Inpatient Ward","41",{"name":156,"value":157},"Nurse Station","42",{"name":159,"value":160},"ICU","43",{"name":162,"value":163},"NICU (Neonatal ICU)","44",{"name":165,"value":166},"Emergency Room (ER)","45",{"name":168,"value":169},"Hospital Corridor","46",{"name":171,"value":172},"Waiting Area","47",{"name":174,"value":175},"CT\u002FMRI","48",{"name":177,"value":178},"Medical Laboratory","49",{"name":180,"value":181},"Phlebotomy Room","50",{"name":183,"value":184},"Rehabilitation Gym","51",{"name":186,"value":187},"Assisted Living Room","52",{"name":189,"value":190},"Pharmacy","53",{"name":192,"value":193},"Sterile Processing Dept","54",{"name":195,"value":196},"Medical Storage","55",{"name":198,"value":17,"add_value":199,"describe":200,"children":201},"Business & Public Service","business","AI is elevating commercial and public services. Our datasets span retail, dining, and service centers to improve intelligent operations.",[202,205,208,211,214,217,220,223,226,229],{"name":203,"value":204},"Shopping Mall Atrium","86",{"name":206,"value":207},"Supermarket Shelf","87",{"name":209,"value":210},"Self-Checkout Counter","88",{"name":212,"value":213},"Restaurant Dining Hall","89",{"name":215,"value":216},"Commercial Kitchen","90",{"name":218,"value":219},"Hotel Lobby","91",{"name":221,"value":222},"Subway Platform","92",{"name":224,"value":225},"Security Checkpoint","93",{"name":227,"value":228},"Underground Parking","94",{"name":230,"value":231},"Bank Teller Zone","95",{"name":233,"value":20,"add_value":234,"describe":235,"children":236},"Industrial & Manufacturing","robot-arm","AI is modernizing industry. Our datasets capture factories and logistics spaces to support robotics and intelligent manufacturing.",[237,240,243,246,249,252,255,258,261,264],{"name":238,"value":239},"Final Assembly Line","96",{"name":241,"value":242},"Quality Control Station","97",{"name":244,"value":245},"Robotic Welding Cell","98",{"name":247,"value":248},"CNC Machining Center","99",{"name":250,"value":251},"Cleanroom","100",{"name":253,"value":254},"Automated Warehouse","101",{"name":256,"value":257},"Loading Dock","102",{"name":259,"value":260},"Sorting Center","103",{"name":262,"value":263},"Chemical Plant","104",{"name":265,"value":266},"Power Substation","105",{"name":268,"value":39,"add_value":269,"describe":270,"children":271},"Transportation & Driving","car","AI is revolutionizing mobility. Our datasets capture road networks, vehicle dynamics and traffic scenarios to support autonomous driving and intelligent transportation systems.",[272,275,278,281,284,287,290,293,296,299],{"name":273,"value":274},"Urban Intersection","56",{"name":276,"value":277},"Highway \u002F Expressway","57",{"name":279,"value":280},"Tunnel","58",{"name":282,"value":283},"Roundabout","59",{"name":285,"value":286},"School \u002F Hospital Zone","60",{"name":288,"value":289},"Toll Station","61",{"name":291,"value":292},"Construction Zone","62",{"name":294,"value":295},"Parking Garage","63",{"name":297,"value":298},"Driver Cabin","64",{"name":300,"value":301},"Adverse Weather","65",{"name":303,"value":42,"add_value":304,"describe":305,"children":306},"Outdoor & Construction","tent-tree","AI is optimizing outdoor operations. Our datasets capture construction sites, open-air work zones and outdoor infrastructure to support smart construction and autonomous outdoor machinery.",[307,310,313,316,319,322,325,328,331,334],{"name":308,"value":309},"Excavation Site","66",{"name":311,"value":312},"Scaffolding Area","67",{"name":314,"value":315},"Material Storage Yard","68",{"name":317,"value":318},"Site Entrance","69",{"name":320,"value":321},"Roadwork Zone","70",{"name":323,"value":324},"Bridge Infrastructure","71",{"name":326,"value":327},"Transmission Line","72",{"name":329,"value":330},"Open-pit Mine","73",{"name":332,"value":333},"Tunneling Site","74",{"name":335,"value":336},"Post-Disaster Rubble","75",{"name":338,"value":45,"add_value":339,"describe":340,"children":341},"Nature, Aerial & Aquatic","global-loop","AI is exploring the natural world. Our datasets capture terrestrial landscapes, aerial vistas and aquatic ecosystems to support environmental monitoring and autonomous exploration systems.",[342,345,348,351,354,357,360,363,366,369],{"name":343,"value":344},"Deep Forest","76",{"name":346,"value":347},"Farmland \u002F Crops","77",{"name":349,"value":350},"River \u002F Lake","78",{"name":352,"value":353},"Open Ocean","79",{"name":355,"value":356},"Underwater Coral Reef","80",{"name":358,"value":359},"Fish Farm","81",{"name":361,"value":362},"Mountain Terrain","82",{"name":364,"value":365},"Urban Low Altitude","83",{"name":367,"value":368},"Fire Scene","84",{"name":370,"value":371},"Desert \u002F Gobi","85",{"name":373,"value":48,"add_value":374,"describe":375,"children":376},"Virtul & Digital","siri","AI is reshaping the virtual realm. Our datasets capture digital twins, virtual environments and simulated spaces to support metaverse development and intelligent digital interaction.",[377,380,383,386,389,392,395,398,401,404],{"name":378,"value":379},"VR Social Space","106",{"name":381,"value":382},"Synthetic Driving Sim","107",{"name":384,"value":385},"Digital Twin City","108",{"name":387,"value":388},"FPS \u002F MOBA Game","109",{"name":390,"value":391},"Robotics Gym","110",{"name":393,"value":394},"AR Navigation","111",{"name":396,"value":397},"Virtual Showroom","112",{"name":399,"value":400},"Code \u002F IDE Interface","113",{"name":402,"value":403},"App GUI Screen","114",{"name":405,"value":406},"Synthetic Face\u002FID","115",[408,411,414,417,420,423,426,429,432,435,438],{"name":409,"value":7,"add_value":410,"describe":8},"Classification","rubric",{"name":412,"value":11,"add_value":413,"describe":8},"Detection","radar",{"name":415,"value":14,"add_value":416,"describe":8},"Segmentation","segmentation",{"name":418,"value":17,"add_value":419,"describe":8},"Tacking","crosshairs",{"name":421,"value":20,"add_value":422,"describe":8},"Estimation","streamline",{"name":424,"value":39,"add_value":425,"describe":8},"QA","qa",{"name":427,"value":42,"add_value":428,"describe":8},"Recognition","finger-scan",{"name":430,"value":45,"add_value":431,"describe":8},"Control","control",{"name":433,"value":48,"add_value":434,"describe":8},"Extraction","extraction",{"name":436,"value":51,"add_value":437,"describe":8},"Retrieval","retrieval",{"name":439,"value":54,"add_value":440,"describe":8},"Forecast","forecast",[442,445,448,451,454,457,460,463,466,469,472,475],{"name":443,"value":7,"add_value":444,"describe":8},"Audio","audio",{"name":446,"value":11,"add_value":447,"describe":8},"Image","image",{"name":449,"value":14,"add_value":450,"describe":8},"Text","text",{"name":452,"value":17,"add_value":453,"describe":8},"Video","video",{"name":455,"value":20,"add_value":456,"describe":8},"Multi","multi",{"name":458,"value":39,"add_value":459,"describe":8},"Document","document",{"name":461,"value":42,"add_value":462,"describe":8},"Time-Series","time-series",{"name":464,"value":45,"add_value":465,"describe":8},"3D cloud","cloud",{"name":467,"value":48,"add_value":468,"describe":8},"Code","code",{"name":470,"value":51,"add_value":471,"describe":8},"Event","event",{"name":473,"value":54,"add_value":474,"describe":8},"Motion","motion",{"name":476,"value":57,"add_value":477,"describe":8},"Interaction","interaction",[479,482,487,491,494,499,504,509,514,519,524,528,532,536,540,544,548,552,556,559],{"id":480,"value":480,"name":233,"intro":481,"add_value":234,"describe":481},2,"智能质检：利用图像识别、多模态模型对产品外观或声音、振动等数据进行分析，自动识别缺陷，提高质量控制效率。\n工业知识问答与文档理解：通过大模型理解和总结技术文档、操作手册，实现快速问答、知识检索和培训支持。\n安全监测与风险预警：实时分析视频、传感器和操作日志，识别潜在危险行为或异常状态，提前预警，保障人员和设备安全。",{"id":483,"value":483,"name":484,"intro":485,"add_value":486,"describe":485},3,"Finance & Insurance","风险评估与预测：分析大量客户数据，评估信用风险、市场风险等，预测违约概率、股价走势等，辅助金融机构决策。\n智能投顾：根据客户风险偏好、资产状况等，提供个性化投资组合建议，实时调整投资策略。\n反欺诈检测：通过分析交易数据、用户行为，识别异常交易和欺诈行为，保障金融安全。","funds",{"id":488,"value":488,"name":489,"intro":490,"add_value":269,"describe":490},1,"Transport & Automotive","智能座舱：打造多模态交互的 AI 座舱，通过语音、手势、面部识别等实现人机交互，如语音控制导航、音乐播放。\n驾驶员状态监测：识别疲劳、分心、抽烟、打电话等行为，通过大模型判断危险等级，触发相应提醒或干预机制。\n智能驾驶：AI 用于环境感知、路径规划与决策控制，使车辆能识别道路、行人、障碍物等，实现自适应巡航、自动泊车、车道保持等功能，提升驾驶安全性与便利性。",{"id":492,"value":492,"name":136,"intro":493,"add_value":137,"describe":493},4,"医学影像诊断：分析 CT、MRI 等影像，辅助医生检测疾病、识别病灶，如 AI 系统可快速发现肺部结节。\n医患对话助手：通过自然语言处理理解患者问题，提供初步健康建议或就诊指导，缓解医生接诊压力。\n智能健康管理：根据用户健康数据，提供个性化健康建议、疾病预警，如智能手环结合 AI 分析用户运动、睡眠、心率等数据。",{"id":495,"value":495,"name":496,"intro":497,"add_value":498,"describe":497},6,"Smart Devices","多模态交互：支持语音、手势、眼神等多种交互方式，如 AI 眼镜可通过语音指令实现翻译、搜索功能。\n智能感知与处理：使设备能感知环境、理解用户需求，如智能音箱根据环境噪音自动调节音量。\n个性化服务：根据用户使用习惯和偏好，提供个性化功能与服务，如智能手表为用户定制运动健身计划。","microscope",{"id":500,"value":500,"name":501,"intro":502,"add_value":503,"describe":502},8,"Law & Government","智能法律问答：面向公众或企业用户，提供合规、劳动法、婚姻继承、知识产权等常见法律问题的智能解答。\n合同审查与风险识别：利用大模型分析合同内容，识别潜在风险条款、漏洞或不合理约定，提升合同审核质量。\n法律知识图谱构建：自动梳理法规、案例、条文之间的引用关系，构建语义化知识图谱，支持智能分析和推理。","hammer",{"id":505,"value":505,"name":506,"intro":507,"add_value":508,"describe":507},7,"Education & Training","个性化学习：根据学生学习进度、能力和知识掌握情况，推送个性化学习内容与练习，如智能辅导系统为学生制定专属学习计划。\n智能教学辅助：AI 助教协助教师进行作业批改、答疑解惑，还可分析教学数据，为教师提供教学反馈，优化教学方法。\n虚拟学习环境：利用 AI 创建虚拟实验、历史场景等，让学生沉浸式学习，如在虚拟化学实验室中进行实验操作。","degree-hat",{"id":510,"value":510,"name":511,"intro":512,"add_value":513,"describe":512},5,"Agriculture & Food","作物病虫害识别与防治：通过图像识别分析农作物叶片、果实等症状，识别病虫害类型，给出防治建议，减少产量损失。\n农产品质量检测：利用图像和传感器数据，识别果蔬等农产品的成熟度、外观缺陷，进行自动分级，提高市场竞争力。\n农情监测与预测：利用卫星遥感、气象和传感器数据，结合大模型预测作物长势、干旱、洪涝等农情变化。","ph-farm",{"id":515,"value":515,"name":516,"intro":517,"add_value":518,"describe":517},9,"Retail & E-commerce","智能客服：通过自然语言对话理解用户需求，提供产品推荐、订单查询、退换货支持等服务，提升客户满意度。\n个性化营销推荐：基于用户浏览、购买、偏好等行为数据，生成个性化推荐内容与优惠策略，提高转化率和客单价。\n商品内容生成：自动撰写商品标题、卖点描述、使用说明等内容，适用于海量SKU的内容生产与多语言发布。","buy",{"id":520,"value":520,"name":521,"intro":522,"add_value":523,"describe":8},10,"Security & Protection",null,"safe-shield-line",{"id":525,"value":525,"name":526,"intro":522,"add_value":527,"describe":8},11,"Environment & Climate","weather",{"id":529,"value":529,"name":530,"intro":522,"add_value":531,"describe":8},12,"Energy & Resource","energy-leaf",{"id":533,"value":533,"name":534,"intro":522,"add_value":535,"describe":8},13,"Express & Logistics","speed-outline",{"id":537,"value":537,"name":538,"intro":522,"add_value":539,"describe":8},15,"Sports","baseball-outline",{"id":541,"value":541,"name":542,"intro":522,"add_value":543,"describe":8},16,"General Data","daily-booth",{"id":545,"value":545,"name":546,"intro":522,"add_value":547,"describe":8},17,"Content & Media","media",{"id":549,"value":549,"name":550,"intro":522,"add_value":551,"describe":8},18,"Construction","construction",{"id":553,"value":553,"name":554,"intro":522,"add_value":555,"describe":8},19,"IT & Telecom","tech",{"id":557,"value":557,"name":558,"intro":522,"add_value":498,"describe":8},20,"Science & Research",{"id":560,"value":560,"name":561,"intro":522,"add_value":562,"describe":8},21,"Language & Culture","lang",{"id":564,"unique_code":565,"title":566,"icon":8,"intro":567,"cate":483,"detail":568,"create_time":569,"update_time":570,"price":571,"view_count":505,"download_count":572,"unit":572,"amount":573,"is_create_order":572,"enterprise_id":488,"seo_keywords":574,"seo_description":575,"data_format":576,"file_size":577,"apply_scene":578,"training_task":579,"version":580,"dataset_type_id":492,"dataset_scene_id":500,"sample_file":581,"banner":8,"unit_name":8,"cate_name":449,"icon_url":8,"banner_url":8,"sample_file_url":8,"data_dict":582,"qa_list":670,"sample_metadatas":687,"text_sample_content":754,"enterprise_name":755,"enterprise_logo":756,"data_distribution":757},1267,"9c7196f0d8f5b2732a7c17a5d08dd0df","Patent and Technology License Agreement Retrieval Dataset","Built around key technology commercialization license terms, this dataset supports precise retrieval, structured extraction, and evidence traceability.","\u003Cp>This dataset focuses on patent and technology license documents, covering key terms such as licensed patent scope, delivery of technical materials, field and territory restrictions, manufacturing and sales rights, improvements, infringement handling, export compliance, and financial terms. Its content supports clause-level retrieval and structured extraction, while source excerpts and locations help users verify search results. It is suitable for legal document RAG, technology commercialization license review, contract research, and legal knowledge base development.\u003C\u002Fp>","2026-10-15 18:09:41","2026-10-19 17:19:12","0.00",0,5000,"patent license dataset,technology license agreement,license clause retrieval,legal document RAG,technology commercialization contracts,patent contract analysis,license rights extraction,legal knowledge base","Covers rights, restrictions, payments, and infringement terms in patent and technology licenses for legal RAG retrieval, structured extraction, and evidence-tr.","JSON","0.3GB","patent licensing, technology commercialization, license agreement review","legal document retrieval, structured term extraction, evidence traceability","V1.0","rivo\u002Fsample-packages\u002F96b1424f-f3fb-44bb-bfdf-6cf5e5a467eb\u002F20261015.zip",[583,588,594,599,605,610,615,620,625,630,635,640,645,650,655,660,665],{"id":572,"name":584,"field":585,"intro":586,"type":587},"File Name","file_name","File name","string",{"id":589,"name":590,"field":591,"intro":592,"type":593},9296,"Agreement Parties","parties","The licensor, licensee, and other relevant entities identified in the document.","array",{"id":595,"name":596,"field":597,"intro":598,"type":587},9297,"Source License Document Text","source_text","The original text of a patent or technology license agreement, serving as the sole raw input for structured extraction and retrieval.",{"id":600,"name":601,"field":602,"intro":603,"type":604},9298,"Improvement Technology Arrangements","improvements","Provisions on improvements to licensed technology, derivative technology, ownership of results, disclosure, and grant-back rights.","object",{"id":606,"name":607,"field":608,"intro":609,"type":587},9299,"Document Type","document_type","The document type identified from its content, such as a patent license agreement, technology license agreement, amendment, or technology transfer agreement.",{"id":611,"name":612,"field":613,"intro":614,"type":604},9300,"Export and Compliance Restrictions","export_control","A summary of obligations concerning the export or re-export of technology, products, and materials, as well as related trade compliance.",{"id":616,"name":617,"field":618,"intro":619,"type":593},9301,"Clause Evidence","clause_evidence","Source clause excerpts and their locations supporting structured conclusions, for retrieval traceability and answer generation.",{"id":621,"name":622,"field":623,"intro":624,"type":604},9302,"Financial and Payment Terms","financial_terms","Extracted terms for license fees, milestone payments, sales royalties, reporting, audits, and payment timing.",{"id":626,"name":627,"field":628,"intro":629,"type":593},9303,"Key Obligations","key_obligations","Key party obligations extracted from the license document, including performance deadlines, triggering conditions, and consequences of breach.",{"id":631,"name":632,"field":633,"intro":634,"type":604},9304,"Licensed Rights","licensed_rights","Extracted commercial rights, including rights to manufacture, use, sell, import, practice, and sublicense.",{"id":636,"name":637,"field":638,"intro":639,"type":587},9305,"Document Summary","document_summary","A consolidated summary of the transaction background, core license arrangements, and principal restrictions in the document.",{"id":641,"name":642,"field":643,"intro":644,"type":593},9306,"Retrieval Keywords","retrieval_keywords","Professional keywords generated from license terms to support RAG retrieval and semantic recall.",{"id":646,"name":647,"field":648,"intro":649,"type":604},9307,"Licensed Patent Scope","licensed_patent_scope","Identification and summary of the licensed patents, patent applications, and related technology.",{"id":651,"name":652,"field":653,"intro":654,"type":604},9308,"Manufacturing and Sales Terms","manufacturing_sales_terms","A summary of terms governing licensed product manufacturing, quality, sales, marking, and commercialization commitments.",{"id":656,"name":657,"field":658,"intro":659,"type":604},9309,"Technical Material Delivery","technical_material_delivery","A structured description of delivery arrangements for technical materials, drawings, samples, source files, and technical support.",{"id":661,"name":662,"field":663,"intro":664,"type":604},9310,"Infringement Handling and Enforcement","infringement_and_enforcement","Extracted terms on identifying and notifying third-party infringement, litigation, cost allocation, and settlement control.",{"id":666,"name":667,"field":668,"intro":669,"type":604},9311,"Field and Territory Restrictions","field_and_territory_restrictions","Restrictions on the permitted fields of use, territories, customers, channels, and exclusivity of the licensed technology.",[671,675,679,683],{"id":672,"question":673,"answer":674},6519,"What license information does the dataset cover?","It focuses on patent and technology license documents, including license scope, technical material delivery, manufacturing and sales rights, field and territory restrictions, improvements, infringement handling, export compliance, and financial terms.",{"id":676,"question":677,"answer":678},6520,"How can users verify retrieval results?","The schema includes source document text, document summaries, retrieval keywords, and clause evidence. Clause evidence can link excerpts to source locations, helping users check structured results and trace the basis for generated answers.",{"id":680,"question":681,"answer":682},6521,"Which applications is the dataset suitable for?","It can support the development or evaluation of legal document RAG systems, license clause retrieval and extraction tools, technology commercialization contract review workflows, and specialized patent and technology licensing knowledge bases.",{"id":684,"question":685,"answer":686},6522,"How can I obtain the data and confirm its license?","Refer to the product page for the available delivery method, sample data, and licensing terms. Before use, confirm the permitted scope, use cases, and redistribution restrictions. The dataset can support retrieval and research but does not replace legal advice from a qualified lawyer.",[688,712,733],{"id":689,"relate_table":690,"relate_id":691,"file_size":572,"file_name":692,"path":8,"duration":572,"cate":483,"file_format":693,"audio_rate":8,"audio_channel":522,"audio_bit_depth":522,"quality":8,"annotation":694,"cate_name":695,"parties":696,"source_text":697,"improvements":698,"document_type":699,"export_control":700,"clause_evidence":701,"financial_terms":702,"key_obligations":703,"licensed_rights":704,"document_summary":705,"retrieval_keywords":706,"licensed_patent_scope":707,"manufacturing_sales_terms":708,"technical_material_delivery":709,"infringement_and_enforcement":710,"field_and_territory_restrictions":711},15201,"union_cubo",896212910,"样例_3.json","json","{\"parties\": \"[{\\\"party_name\\\": \\\"Yaochen Optoelectronics Technology Co., Ltd.\\\", \\\"party_role\\\": \\\"Licensor\\\", \\\"entity_type\\\": \\\"Company\\\", \\\"jurisdiction\\\": \\\"Mainland China\\\"}, {\\\"party_name\\\": \\\"Hengchuan Manufacturing Group Co., Ltd.\\\", \\\"party_role\\\": \\\"Licensee\\\", \\\"entity_type\\\": \\\"Company\\\", \\\"jurisdiction\\\": \\\"Mainland China\\\"}]\", \"source_text\": \"Non-exclusive Patent License Agreement for Photovoltaic Module Encapsulation Technology\\nLicensor: Yaochen Optoelectronics Technology Co., Ltd.; Licensee: Hengchuan Manufacturing Group Co., Ltd.\\nArticle 1 Licensed Patents. The licensed patents include the licensor's Chinese patents CN216789012B and CN218901234A relating to high-barrier flexible photovoltaic module encapsulation films, edge sealing structures, and online defect detection methods, and granted patents derived from the priority of the above patents within the licensed territory. The scope does not include organic photovoltaic devices or core material formulations for perovskite cells not listed by the licensor.\\nArticle 2 Technical Materials. The licensor shall, within 20 working days after the first license fee is received, deliver the encapsulation film lamination temperature window, equipment calibration specifications, detection algorithm interface specifications, three sets of test samples, and a quality control checklist. Materials shall be transmitted through encrypted files, and English equipment interface documents shall be accompanied by Chinese summaries. The licensee shall raise objections within 10 working days, and the licensor shall provide 90 days of remote debugging support.\\nArticle 3 Rights. The licensor grants the licensee a non-exclusive license to manufacture, use, sell, offer for sale, and import licensed products in Japan, Germany, and Vietnam. The licensee may use approved suppliers for its own production purposes, but may not grant sublicenses or assign patent practice rights to third parties. The licensor and its existing customers may continue to practice and license the licensed patents worldwide.\\nArticle 4 Field, Customers, and Channels. Licensed products are limited to crystalline silicon photovoltaic module encapsulation films and module edge sealing systems and may not be used in aerospace, military optoelectronics, or medical implant devices. The licensee may not sell through unregistered distributors and may not supply sanctioned entities. Direct sales are permitted in the Japanese market, while the German and Vietnamese markets must be served through the licensee's own sales entities.\\nArticle 5 Manufacturing and Commercialization. The licensee shall manufacture in factories certified to ISO 14001, use key raw materials approved by the licensor, and accept one quality audit per year by the licensor. Products shall be marked with a patent license notice and batch traceability code. The licensee shall complete first article certification within 12 months after the agreement takes effect and achieve net sales of no less than RMB 150 million in the second year; if the target is not met, the licensor may require a rectification plan, but the license nature will not automatically change.\\nArticle 6 Improvements. Equipment adaptations, online detection parameters, and encapsulation process improvements independently developed by the licensee belong to the licensee. For improvements involving claims of the licensed patents, the licensee shall notify the licensor 45 days before filing and grant the licensor a non-exclusive license within the licensor's existing photovoltaic product lines. The licensor is not obligated to automatically license its improvements to the licensee, but the parties may separately sign license documents.\\nArticle 7 Infringement Handling. Upon discovering third-party infringement, the discovering party shall notify within 7 days. Either party may take enforcement action in the market where it is directly harmed, but shall notify the other party 30 days in advance; the other party shall provide reasonable assistance. Enforcement costs shall be borne by the initiating party, and net damages obtained shall belong to the initiating party; cases involving a common market of both parties shall be decided through consultation. Settlements may not include acknowledgment or waiver of the validity of the licensed patents.\\nArticle 8 Export Restrictions. The parties shall comply with export control, customs, and sanctions regulations of Japan, Germany, Vietnam, and the actual places of export of goods and technology. Without necessary government licenses, the encapsulation film formulations, detection algorithm interfaces, or production parameters may not be re-exported to controlled destinations.\\nArticle 9 Fees and Audit. The licensee shall pay an initial license fee of RMB 2 million and tiered royalties on net sales: 2% for annual net sales up to RMB 50 million and 3% for the excess. Reports and payments shall be submitted within 40 days after the end of each quarter, and the licensor may audit once per year.\", \"improvements\": \"{\\\"improvement_definition\\\": \\\"Optimization, upgrades, or derivative development of equipment adaptation, online detection parameters, lamination processes, and edge sealing processes.\\\", \\\"ownership\\\": \\\"Equipment adaptations, detection parameters, and encapsulation process improvements independently developed by the licensee belong to the licensee.\\\", \\\"disclosure_obligation\\\": \\\"For improvements involving claims of the licensed patents, the licensee shall notify the licensor 45 days before filing a patent application.\\\", \\\"license_back\\\": \\\"The licensee grants the licensor a non-exclusive license to use the relevant improvements within the licensor's existing photovoltaic product lines.\\\", \\\"invention_assignment\\\": \\\"No automatic assignment of invention rights occurs between the parties; if joint filing or cross-licensing is needed, the parties shall sign separate written documents.\\\"}\", \"document_type\": \"Non-exclusive Patent License Agreement\", \"export_control\": \"{\\\"controlled_destinations\\\": [\\\"Controlled destinations under applicable Japanese export controls\\\", \\\"Controlled destinations under applicable German or EU export controls\\\", \\\"Controlled destinations under applicable Vietnamese trade restrictions\\\", \\\"Entities on sanctions lists in each jurisdiction\\\"], \\\"compliance_obligations\\\": \\\"The parties shall comply with export control, customs, sanctions, and re-export laws of the actual places of export of products and technology, and shall manage classification of formulations, algorithm interfaces, and production parameters.\\\", \\\"required_approvals\\\": \\\"Before exporting or re-exporting to controlled destinations, relevant government export licenses, customs approvals, and internal compliance approvals shall be obtained.\\\", \\\"prohibited_transactions\\\": \\\"It is prohibited to re-export encapsulation film formulations, detection algorithm interfaces, and production parameters to controlled destinations without approval, and to supply sanctioned entities.\\\"}\", \"clause_evidence\": \"[{\\\"clause_topic\\\": \\\"Scope of licensed patents\\\", \\\"quote\\\": \\\"The licensed patents include the licensor's Chinese patents CN216789012B and CN218901234A relating to high-barrier flexible photovoltaic module encapsulation films, edge sealing structures, and online defect detection methods.\\\", \\\"source_location\\\": \\\"Article 1 Licensed Patents\\\", \\\"relevance\\\": \\\"Lists the licensed patent identifiers and corresponding encapsulation and detection technology subject matter.\\\"}, {\\\"clause_topic\\\": \\\"Non-exclusive license rights\\\", \\\"quote\\\": \\\"The licensor grants the licensee a non-exclusive license to manufacture, use, sell, offer for sale, and import licensed products in Japan, Germany, and Vietnam.\\\", \\\"source_location\\\": \\\"Article 3 Rights\\\", \\\"relevance\\\": \\\"Clarifies the license nature, territory, and commercialization rights such as manufacturing and sales.\\\"}, {\\\"clause_topic\\\": \\\"Channel and customer restrictions\\\", \\\"quote\\\": \\\"The licensee may not sell through unregistered distributors and may not supply sanctioned entities.\\\", \\\"source_location\\\": \\\"Article 4 Field, Customers, and Channels\\\", \\\"relevance\\\": \\\"Supports structured extraction of sales channel and customer compliance restrictions.\\\"}, {\\\"clause_topic\\\": \\\"Improvement grant-back license\\\", \\\"quote\\\": \\\"For improvements involving claims of the licensed patents, the licensee shall notify the licensor 45 days before filing and grant the licensor a non-exclusive license within the licensor's existing photovoltaic product lines.\\\", \\\"source_location\\\": \\\"Article 6 Improvements\\\", \\\"relevance\\\": \\\"States the improvement notice period, improvement scope, and limited grant-back license.\\\"}, {\\\"clause_topic\\\": \\\"Tiered royalties\\\", \\\"quote\\\": \\\"Tiered royalties on net sales: 2% for annual net sales up to RMB 50 million and 3% for the excess.\\\", \\\"source_location\\\": \\\"Article 9 Fees and Audit\\\", \\\"relevance\\\": \\\"Clarifies the royalty calculation basis and tiered rates, applicable to economic term searches.\\\"}]\", \"financial_terms\": \"{\\\"royalty_basis\\\": \\\"Net sales of licensed products in the licensed territory, calculated on cumulative annual net sales.\\\", \\\"royalty_rate\\\": \\\"2% for the portion of annual net sales up to RMB 50 million and 3% for the excess.\\\", \\\"milestone_or_lump_sum\\\": \\\"An initial license fee of RMB 2 million payable after the agreement takes effect and payment conditions are met; no additional milestone payments are stipulated.\\\", \\\"reporting_and_audit\\\": \\\"Sales reports submitted within 40 days after the end of each quarter; the licensor may audit sales, production, and distribution records once per year.\\\", \\\"payment_timing\\\": \\\"Reports and royalty payments completed within 40 days after the end of each quarter; if an audit finds underreporting, the difference shall be paid after notice.\\\"}\", \"key_obligations\": \"[{\\\"obligor\\\": \\\"Yaochen Optoelectronics Technology Co., Ltd.\\\", \\\"obligation\\\": \\\"Deliver encapsulation process, equipment calibration, detection interface, and quality control materials, and provide remote debugging support.\\\", \\\"deadline\\\": \\\"Delivered within 20 working days after the initial license fee is received; support provided within 90 days after delivery.\\\", \\\"trigger\\\": \\\"Receipt of the initial license fee.\\\", \\\"consequence\\\": \\\"If materials are delayed or materially defective, the licensee may raise objections and require remediation, and the relevant support period shall be extended accordingly.\\\"}, {\\\"obligor\\\": \\\"Hengchuan Manufacturing Group Co., Ltd.\\\", \\\"obligation\\\": \\\"Manufacture at certified factories using approved raw materials and processes, and accept quality audits.\\\", \\\"deadline\\\": \\\"Continuous performance during the agreement term.\\\", \\\"trigger\\\": \\\"Starting production of licensed products.\\\", \\\"consequence\\\": \\\"Serious violation of quality requirements or refusal of audits may constitute material breach and lead to suspension of the license.\\\"}, {\\\"obligor\\\": \\\"Hengchuan Manufacturing Group Co., Ltd.\\\", \\\"obligation\\\": \\\"Complete first article certification and achieve net sales of no less than RMB 150 million in the second year.\\\", \\\"deadline\\\": \\\"First article certification completed within 12 months after the agreement takes effect; sales target verified in the second year.\\\", \\\"trigger\\\": \\\"Agreement effectiveness and commencement of commercial production.\\\", \\\"consequence\\\": \\\"If the sales target is not met, submit a rectification plan, but the non-exclusive license is not automatically changed to another license type.\\\"}, {\\\"obligor\\\": \\\"Hengchuan Manufacturing Group Co., Ltd.\\\", \\\"obligation\\\": \\\"Pay tiered royalties and submit quarterly sales reports.\\\", \\\"deadline\\\": \\\"Within 40 days after the end of each quarter.\\\", \\\"trigger\\\": \\\"Sales of licensed products occur.\\\", \\\"consequence\\\": \\\"For late reporting or underreporting, the licensor may audit and require payment of the difference and applicable interest.\\\"}, {\\\"obligor\\\": \\\"Both parties\\\", \\\"obligation\\\": \\\"Comply with export control, sanctions, and re-export restrictions and not transfer technology or products to controlled entities.\\\", \\\"deadline\\\": \\\"Before each export, re-export, or supply.\\\", \\\"trigger\\\": \\\"Cross-border transfer or sale to overseas customers occurs.\\\", \\\"consequence\\\": \\\"Violation of restrictions may lead to suspension of transactions, suspension or termination of the license, and compliance liability borne by the responsible party.\\\"}]\", \"licensed_rights\": \"{\\\"grant_type\\\": \\\"Non-exclusive License\\\", \\\"manufacturing_rights\\\": \\\"The licensee may manufacture licensed products within the licensed territory and may use suppliers approved by the licensor for its own production purposes.\\\", \\\"use_rights\\\": \\\"May use the encapsulation film, edge sealing, and detection technologies in the crystalline silicon photovoltaic module encapsulation field for production and quality control.\\\", \\\"sales_rights\\\": \\\"May offer for sale, sell, and import licensed products in Japan, Germany, and Vietnam, subject to customer, channel, sanctions, and territory requirements.\\\", \\\"sublicensing_rights\\\": \\\"May not grant sublicenses or assign patent practice rights to third parties; use of approved suppliers does not constitute sublicensing.\\\", \\\"reservation_of_rights\\\": \\\"The licensor and its existing customers reserve all rights not granted to practice and license the licensed patents worldwide.\\\"}\", \"document_summary\": \"This is a non-exclusive license granted by Yaochen Optoelectronics Technology Co., Ltd. to Hengchuan Manufacturing Group Co., Ltd. for photovoltaic module encapsulation technology. The license covers high-barrier flexible encapsulation films, edge sealing structures, and online defect detection patents and permits the licensee to manufacture, use, sell, and import crystalline silicon photovoltaic module encapsulation products in Japan, Germany, and Vietnam. The agreement restricts application fields, distributors, and sanctioned customers, and provides for material delivery, quality audits, first article certification, sales targets, improvement notices and license grant-back, tiered royalties, and export compliance obligations.\", \"retrieval_keywords\": \"[\\\"photovoltaic module encapsulation patent license\\\", \\\"high-barrier flexible encapsulation film\\\", \\\"non-exclusive edge sealing technology license\\\", \\\"online defect detection algorithm\\\", \\\"Japan Germany Vietnam licensed territory\\\", \\\"patent marking for licensed photovoltaic products\\\", \\\"first article certification and sales target\\\", \\\"tiered royalty rates\\\", \\\"grant-back license for improvements\\\", \\\"distributor channel restrictions\\\", \\\"photovoltaic technology export control\\\"]\", \"licensed_patent_scope\": \"{\\\"scope_definition\\\": \\\"The licensed patents include the listed Chinese patents relating to high-barrier flexible photovoltaic module encapsulation films, edge sealing structures, and online defect detection methods, and patents derived from their priority and granted within the licensed territory.\\\", \\\"patent_identifiers\\\": [\\\"CN216789012B\\\", \\\"CN218901234A\\\", \\\"granted patents in the licensed territory derived from the priority of the above patents\\\"], \\\"covered_technology\\\": \\\"Crystalline silicon photovoltaic module encapsulation films, module edge sealing structures, lamination processes, and online defect detection methods.\\\", \\\"included_rights\\\": \\\"Non-exclusive patent practice rights to manufacture, use, offer for sale, sell, and import licensed products in Japan, Germany, and Vietnam, and the right to use related technical materials for the licensee's own production.\\\", \\\"exclusions\\\": \\\"Excludes organic photovoltaic devices, core material formulations for perovskite cells, and aerospace, military optoelectronics, and medical implant device uses.\\\", \\\"status_and_maintenance\\\": \\\"The licensor is responsible for annuity fees and maintenance of the licensed patents and shall promptly notify the licensee of patent invalidation, abandonment, or material changes in claim scope.\\\"}\", \"manufacturing_sales_terms\": \"{\\\"manufacturing_obligations\\\": \\\"The licensee shall manufacture in factories certified to ISO 14001 and use key raw materials and process parameters approved by the licensor.\\\", \\\"quality_control\\\": \\\"The licensee shall inspect according to the quality control checklist; the licensor may conduct one quality audit per year; products shall have batch traceability records.\\\", \\\"sales_obligations\\\": \\\"The licensee shall complete first article certification and conduct sales development within the licensed territory, and submit quarterly sales reports.\\\", \\\"marking_and_notice\\\": \\\"Products must be marked with a patent license notice and batch traceability code, and promotional materials may not imply exclusivity.\\\", \\\"minimum_commitments\\\": \\\"Complete first article certification within 12 months after the agreement takes effect; second-year net sales target of no less than RMB 150 million; if not met, submit a rectification plan but the license nature does not automatically change.\\\"}\", \"technical_material_delivery\": \"{\\\"materials\\\": [\\\"Encapsulation film lamination temperature window\\\", \\\"Equipment calibration specifications\\\", \\\"Online defect detection algorithm interface specifications\\\", \\\"Three sets of test samples\\\", \\\"Quality control checklist\\\"], \\\"delivery_deadline\\\": \\\"Delivered within 20 working days after the initial license fee is received; 90 days of remote debugging support provided after delivery.\\\", \\\"delivery_format\\\": \\\"Transmitted through encrypted files; English equipment interface documents accompanied by Chinese summaries.\\\", \\\"acceptance_and_support\\\": \\\"The licensee shall raise material objections within 10 working days; the licensor shall provide 90 days of remote debugging and interface adaptation support.\\\", \\\"confidentiality_requirements\\\": \\\"Materials may be used only by the licensee's internal production, quality, and R&D personnel and may not be copied, disclosed, or transferred to unregistered distributors or other third parties.\\\"}\", \"infringement_and_enforcement\": \"{\\\"infringement_notification\\\": \\\"Upon discovering third-party infringement, the discovering party shall notify the other party within 7 days and provide available infringement evidence.\\\", \\\"enforcement_rights\\\": \\\"Either party may take administrative or civil enforcement action in the market where it is directly harmed, but shall notify the other party 30 days in advance; cases involving a common market of both parties shall be decided through consultation.\\\", \\\"cost_and_recovery\\\": \\\"Enforcement costs are borne by the initiating party, and net damages obtained belong to the initiating party; costs and proceeds in common market cases shall be separately negotiated.\\\", \\\"cooperation\\\": \\\"The other party shall provide patent documents, product samples, technical opinions, and necessary witness assistance, but reasonable external costs shall be borne by the initiating party.\\\", \\\"settlement_control\\\": \\\"Settlements may not include acknowledgment or waiver of the validity of the licensed patents or restrict the other party from continuing to practice the licensed rights.\\\"}\", \"field_and_territory_restrictions\": \"{\\\"application_fields\\\": [\\\"Crystalline silicon photovoltaic module encapsulation films\\\", \\\"Crystalline silicon photovoltaic module edge sealing systems\\\", \\\"Online defect detection for photovoltaic modules\\\"], \\\"territories\\\": [\\\"Japan\\\", \\\"Germany\\\", \\\"Vietnam\\\"], \\\"customer_restrictions\\\": \\\"May not supply sanctioned entities or customers intending to use the products in aerospace, military optoelectronics, or medical implant devices.\\\", \\\"channel_restrictions\\\": \\\"May not sell through unregistered distributors; direct sales are permitted in Japan, while Germany and Vietnam must be served through the licensee's own sales entities.\\\", \\\"exclusivity\\\": \\\"Non-exclusive license; the licensor and existing customers may continue to practice or license the licensed patents, with no market exclusivity.\\\"}\"}","文本","[{\"party_name\": \"Yaochen Optoelectronics Technology Co., Ltd.\", \"party_role\": \"Licensor\", \"entity_type\": \"Company\", \"jurisdiction\": \"Mainland China\"}, {\"party_name\": \"Hengchuan Manufacturing Group Co., Ltd.\", \"party_role\": \"Licensee\", \"entity_type\": \"Company\", \"jurisdiction\": \"Mainland China\"}]","Non-exclusive Patent License Agreement for Photovoltaic Module Encapsulation Technology\nLicensor: Yaochen Optoelectronics Technology Co., Ltd.; Licensee: Hengchuan Manufacturing Group Co., Ltd.\nArticle 1 Licensed Patents. The licensed patents include the licensor's Chinese patents CN216789012B and CN218901234A relating to high-barrier flexible photovoltaic module encapsulation films, edge sealing structures, and online defect detection methods, and granted patents derived from the priority of the above patents within the licensed territory. The scope does not include organic photovoltaic devices or core material formulations for perovskite cells not listed by the licensor.\nArticle 2 Technical Materials. The licensor shall, within 20 working days after the first license fee is received, deliver the encapsulation film lamination temperature window, equipment calibration specifications, detection algorithm interface specifications, three sets of test samples, and a quality control checklist. Materials shall be transmitted through encrypted files, and English equipment interface documents shall be accompanied by Chinese summaries. The licensee shall raise objections within 10 working days, and the licensor shall provide 90 days of remote debugging support.\nArticle 3 Rights. The licensor grants the licensee a non-exclusive license to manufacture, use, sell, offer for sale, and import licensed products in Japan, Germany, and Vietnam. The licensee may use approved suppliers for its own production purposes, but may not grant sublicenses or assign patent practice rights to third parties. The licensor and its existing customers may continue to practice and license the licensed patents worldwide.\nArticle 4 Field, Customers, and Channels. Licensed products are limited to crystalline silicon photovoltaic module encapsulation films and module edge sealing systems and may not be used in aerospace, military optoelectronics, or medical implant devices. The licensee may not sell through unregistered distributors and may not supply sanctioned entities. Direct sales are permitted in the Japanese market, while the German and Vietnamese markets must be served through the licensee's own sales entities.\nArticle 5 Manufacturing and Commercialization. The licensee shall manufacture in factories certified to ISO 14001, use key raw materials approved by the licensor, and accept one quality audit per year by the licensor. Products shall be marked with a patent license notice and batch traceability code. The licensee shall complete first article certification within 12 months after the agreement takes effect and achieve net sales of no less than RMB 150 million in the second year; if the target is not met, the licensor may require a rectification plan, but the license nature will not automatically change.\nArticle 6 Improvements. Equipment adaptations, online detection parameters, and encapsulation process improvements independently developed by the licensee belong to the licensee. For improvements involving claims of the licensed patents, the licensee shall notify the licensor 45 days before filing and grant the licensor a non-exclusive license within the licensor's existing photovoltaic product lines. The licensor is not obligated to automatically license its improvements to the licensee, but the parties may separately sign license documents.\nArticle 7 Infringement Handling. Upon discovering third-party infringement, the discovering party shall notify within 7 days. Either party may take enforcement action in the market where it is directly harmed, but shall notify the other party 30 days in advance; the other party shall provide reasonable assistance. Enforcement costs shall be borne by the initiating party, and net damages obtained shall belong to the initiating party; cases involving a common market of both parties shall be decided through consultation. Settlements may not include acknowledgment or waiver of the validity of the licensed patents.\nArticle 8 Export Restrictions. The parties shall comply with export control, customs, and sanctions regulations of Japan, Germany, Vietnam, and the actual places of export of goods and technology. Without necessary government licenses, the encapsulation film formulations, detection algorithm interfaces, or production parameters may not be re-exported to controlled destinations.\nArticle 9 Fees and Audit. The licensee shall pay an initial license fee of RMB 2 million and tiered royalties on net sales: 2% for annual net sales up to RMB 50 million and 3% for the excess. Reports and payments shall be submitted within 40 days after the end of each quarter, and the licensor may audit once per year.","{\"improvement_definition\": \"Optimization, upgrades, or derivative development of equipment adaptation, online detection parameters, lamination processes, and edge sealing processes.\", \"ownership\": \"Equipment adaptations, detection parameters, and encapsulation process improvements independently developed by the licensee belong to the licensee.\", \"disclosure_obligation\": \"For improvements involving claims of the licensed patents, the licensee shall notify the licensor 45 days before filing a patent application.\", \"license_back\": \"The licensee grants the licensor a non-exclusive license to use the relevant improvements within the licensor's existing photovoltaic product lines.\", \"invention_assignment\": \"No automatic assignment of invention rights occurs between the parties; if joint filing or cross-licensing is needed, the parties shall sign separate written documents.\"}","Non-exclusive Patent License Agreement","{\"controlled_destinations\": [\"Controlled destinations under applicable Japanese export controls\", \"Controlled destinations under applicable German or EU export controls\", \"Controlled destinations under applicable Vietnamese trade restrictions\", \"Entities on sanctions lists in each jurisdiction\"], \"compliance_obligations\": \"The parties shall comply with export control, customs, sanctions, and re-export laws of the actual places of export of products and technology, and shall manage classification of formulations, algorithm interfaces, and production parameters.\", \"required_approvals\": \"Before exporting or re-exporting to controlled destinations, relevant government export licenses, customs approvals, and internal compliance approvals shall be obtained.\", \"prohibited_transactions\": \"It is prohibited to re-export encapsulation film formulations, detection algorithm interfaces, and production parameters to controlled destinations without approval, and to supply sanctioned entities.\"}","[{\"clause_topic\": \"Scope of licensed patents\", \"quote\": \"The licensed patents include the licensor's Chinese patents CN216789012B and CN218901234A relating to high-barrier flexible photovoltaic module encapsulation films, edge sealing structures, and online defect detection methods.\", \"source_location\": \"Article 1 Licensed Patents\", \"relevance\": \"Lists the licensed patent identifiers and corresponding encapsulation and detection technology subject matter.\"}, {\"clause_topic\": \"Non-exclusive license rights\", \"quote\": \"The licensor grants the licensee a non-exclusive license to manufacture, use, sell, offer for sale, and import licensed products in Japan, Germany, and Vietnam.\", \"source_location\": \"Article 3 Rights\", \"relevance\": \"Clarifies the license nature, territory, and commercialization rights such as manufacturing and sales.\"}, {\"clause_topic\": \"Channel and customer restrictions\", \"quote\": \"The licensee may not sell through unregistered distributors and may not supply sanctioned entities.\", \"source_location\": \"Article 4 Field, Customers, and Channels\", \"relevance\": \"Supports structured extraction of sales channel and customer compliance restrictions.\"}, {\"clause_topic\": \"Improvement grant-back license\", \"quote\": \"For improvements involving claims of the licensed patents, the licensee shall notify the licensor 45 days before filing and grant the licensor a non-exclusive license within the licensor's existing photovoltaic product lines.\", \"source_location\": \"Article 6 Improvements\", \"relevance\": \"States the improvement notice period, improvement scope, and limited grant-back license.\"}, {\"clause_topic\": \"Tiered royalties\", \"quote\": \"Tiered royalties on net sales: 2% for annual net sales up to RMB 50 million and 3% for the excess.\", \"source_location\": \"Article 9 Fees and Audit\", \"relevance\": \"Clarifies the royalty calculation basis and tiered rates, applicable to economic term searches.\"}]","{\"royalty_basis\": \"Net sales of licensed products in the licensed territory, calculated on cumulative annual net sales.\", \"royalty_rate\": \"2% for the portion of annual net sales up to RMB 50 million and 3% for the excess.\", \"milestone_or_lump_sum\": \"An initial license fee of RMB 2 million payable after the agreement takes effect and payment conditions are met; no additional milestone payments are stipulated.\", \"reporting_and_audit\": \"Sales reports submitted within 40 days after the end of each quarter; the licensor may audit sales, production, and distribution records once per year.\", \"payment_timing\": \"Reports and royalty payments completed within 40 days after the end of each quarter; if an audit finds underreporting, the difference shall be paid after notice.\"}","[{\"obligor\": \"Yaochen Optoelectronics Technology Co., Ltd.\", \"obligation\": \"Deliver encapsulation process, equipment calibration, detection interface, and quality control materials, and provide remote debugging support.\", \"deadline\": \"Delivered within 20 working days after the initial license fee is received; support provided within 90 days after delivery.\", \"trigger\": \"Receipt of the initial license fee.\", \"consequence\": \"If materials are delayed or materially defective, the licensee may raise objections and require remediation, and the relevant support period shall be extended accordingly.\"}, {\"obligor\": \"Hengchuan Manufacturing Group Co., Ltd.\", \"obligation\": \"Manufacture at certified factories using approved raw materials and processes, and accept quality audits.\", \"deadline\": \"Continuous performance during the agreement term.\", \"trigger\": \"Starting production of licensed products.\", \"consequence\": \"Serious violation of quality requirements or refusal of audits may constitute material breach and lead to suspension of the license.\"}, {\"obligor\": \"Hengchuan Manufacturing Group Co., Ltd.\", \"obligation\": \"Complete first article certification and achieve net sales of no less than RMB 150 million in the second year.\", \"deadline\": \"First article certification completed within 12 months after the agreement takes effect; sales target verified in the second year.\", \"trigger\": \"Agreement effectiveness and commencement of commercial production.\", \"consequence\": \"If the sales target is not met, submit a rectification plan, but the non-exclusive license is not automatically changed to another license type.\"}, {\"obligor\": \"Hengchuan Manufacturing Group Co., Ltd.\", \"obligation\": \"Pay tiered royalties and submit quarterly sales reports.\", \"deadline\": \"Within 40 days after the end of each quarter.\", \"trigger\": \"Sales of licensed products occur.\", \"consequence\": \"For late reporting or underreporting, the licensor may audit and require payment of the difference and applicable interest.\"}, {\"obligor\": \"Both parties\", \"obligation\": \"Comply with export control, sanctions, and re-export restrictions and not transfer technology or products to controlled entities.\", \"deadline\": \"Before each export, re-export, or supply.\", \"trigger\": \"Cross-border transfer or sale to overseas customers occurs.\", \"consequence\": \"Violation of restrictions may lead to suspension of transactions, suspension or termination of the license, and compliance liability borne by the responsible party.\"}]","{\"grant_type\": \"Non-exclusive License\", \"manufacturing_rights\": \"The licensee may manufacture licensed products within the licensed territory and may use suppliers approved by the licensor for its own production purposes.\", \"use_rights\": \"May use the encapsulation film, edge sealing, and detection technologies in the crystalline silicon photovoltaic module encapsulation field for production and quality control.\", \"sales_rights\": \"May offer for sale, sell, and import licensed products in Japan, Germany, and Vietnam, subject to customer, channel, sanctions, and territory requirements.\", \"sublicensing_rights\": \"May not grant sublicenses or assign patent practice rights to third parties; use of approved suppliers does not constitute sublicensing.\", \"reservation_of_rights\": \"The licensor and its existing customers reserve all rights not granted to practice and license the licensed patents worldwide.\"}","This is a non-exclusive license granted by Yaochen Optoelectronics Technology Co., Ltd. to Hengchuan Manufacturing Group Co., Ltd. for photovoltaic module encapsulation technology. The license covers high-barrier flexible encapsulation films, edge sealing structures, and online defect detection patents and permits the licensee to manufacture, use, sell, and import crystalline silicon photovoltaic module encapsulation products in Japan, Germany, and Vietnam. The agreement restricts application fields, distributors, and sanctioned customers, and provides for material delivery, quality audits, first article certification, sales targets, improvement notices and license grant-back, tiered royalties, and export compliance obligations.","[\"photovoltaic module encapsulation patent license\", \"high-barrier flexible encapsulation film\", \"non-exclusive edge sealing technology license\", \"online defect detection algorithm\", \"Japan Germany Vietnam licensed territory\", \"patent marking for licensed photovoltaic products\", \"first article certification and sales target\", \"tiered royalty rates\", \"grant-back license for improvements\", \"distributor channel restrictions\", \"photovoltaic technology export control\"]","{\"scope_definition\": \"The licensed patents include the listed Chinese patents relating to high-barrier flexible photovoltaic module encapsulation films, edge sealing structures, and online defect detection methods, and patents derived from their priority and granted within the licensed territory.\", \"patent_identifiers\": [\"CN216789012B\", \"CN218901234A\", \"granted patents in the licensed territory derived from the priority of the above patents\"], \"covered_technology\": \"Crystalline silicon photovoltaic module encapsulation films, module edge sealing structures, lamination processes, and online defect detection methods.\", \"included_rights\": \"Non-exclusive patent practice rights to manufacture, use, offer for sale, sell, and import licensed products in Japan, Germany, and Vietnam, and the right to use related technical materials for the licensee's own production.\", \"exclusions\": \"Excludes organic photovoltaic devices, core material formulations for perovskite cells, and aerospace, military optoelectronics, and medical implant device uses.\", \"status_and_maintenance\": \"The licensor is responsible for annuity fees and maintenance of the licensed patents and shall promptly notify the licensee of patent invalidation, abandonment, or material changes in claim scope.\"}","{\"manufacturing_obligations\": \"The licensee shall manufacture in factories certified to ISO 14001 and use key raw materials and process parameters approved by the licensor.\", \"quality_control\": \"The licensee shall inspect according to the quality control checklist; the licensor may conduct one quality audit per year; products shall have batch traceability records.\", \"sales_obligations\": \"The licensee shall complete first article certification and conduct sales development within the licensed territory, and submit quarterly sales reports.\", \"marking_and_notice\": \"Products must be marked with a patent license notice and batch traceability code, and promotional materials may not imply exclusivity.\", \"minimum_commitments\": \"Complete first article certification within 12 months after the agreement takes effect; second-year net sales target of no less than RMB 150 million; if not met, submit a rectification plan but the license nature does not automatically change.\"}","{\"materials\": [\"Encapsulation film lamination temperature window\", \"Equipment calibration specifications\", \"Online defect detection algorithm interface specifications\", \"Three sets of test samples\", \"Quality control checklist\"], \"delivery_deadline\": \"Delivered within 20 working days after the initial license fee is received; 90 days of remote debugging support provided after delivery.\", \"delivery_format\": \"Transmitted through encrypted files; English equipment interface documents accompanied by Chinese summaries.\", \"acceptance_and_support\": \"The licensee shall raise material objections within 10 working days; the licensor shall provide 90 days of remote debugging and interface adaptation support.\", \"confidentiality_requirements\": \"Materials may be used only by the licensee's internal production, quality, and R&D personnel and may not be copied, disclosed, or transferred to unregistered distributors or other third parties.\"}","{\"infringement_notification\": \"Upon discovering third-party infringement, the discovering party shall notify the other party within 7 days and provide available infringement evidence.\", \"enforcement_rights\": \"Either party may take administrative or civil enforcement action in the market where it is directly harmed, but shall notify the other party 30 days in advance; cases involving a common market of both parties shall be decided through consultation.\", \"cost_and_recovery\": \"Enforcement costs are borne by the initiating party, and net damages obtained belong to the initiating party; costs and proceeds in common market cases shall be separately negotiated.\", \"cooperation\": \"The other party shall provide patent documents, product samples, technical opinions, and necessary witness assistance, but reasonable external costs shall be borne by the initiating party.\", \"settlement_control\": \"Settlements may not include acknowledgment or waiver of the validity of the licensed patents or restrict the other party from continuing to practice the licensed rights.\"}","{\"application_fields\": [\"Crystalline silicon photovoltaic module encapsulation films\", \"Crystalline silicon photovoltaic module edge sealing systems\", \"Online defect detection for photovoltaic modules\"], \"territories\": [\"Japan\", \"Germany\", \"Vietnam\"], \"customer_restrictions\": \"May not supply sanctioned entities or customers intending to use the products in aerospace, military optoelectronics, or medical implant devices.\", \"channel_restrictions\": \"May not sell through unregistered distributors; direct sales are permitted in Japan, while Germany and Vietnam must be served through the licensee's own sales entities.\", \"exclusivity\": \"Non-exclusive license; the licensor and existing customers may continue to practice or license the licensed patents, with no market exclusivity.\"}",{"id":713,"relate_table":690,"relate_id":714,"file_size":572,"file_name":715,"path":8,"duration":572,"cate":483,"file_format":693,"audio_rate":8,"audio_channel":522,"audio_bit_depth":522,"quality":8,"annotation":716,"cate_name":695,"parties":717,"source_text":718,"improvements":719,"document_type":720,"export_control":721,"clause_evidence":722,"financial_terms":723,"key_obligations":724,"licensed_rights":725,"document_summary":726,"retrieval_keywords":727,"licensed_patent_scope":728,"manufacturing_sales_terms":729,"technical_material_delivery":730,"infringement_and_enforcement":731,"field_and_territory_restrictions":732},15200,1635028323,"样例_2.json","{\"parties\": \"[{\\\"party_name\\\": \\\"Beilan Bioengineering University\\\", \\\"party_role\\\": \\\"Licensor\\\", \\\"entity_type\\\": \\\"University\\\", \\\"jurisdiction\\\": \\\"Mainland China\\\"}, {\\\"party_name\\\": \\\"Qingyue Pharmaceutical Manufacturing Co., Ltd.\\\", \\\"party_role\\\": \\\"Licensee\\\", \\\"entity_type\\\": \\\"Company\\\", \\\"jurisdiction\\\": \\\"Mainland China\\\"}]\", \"source_text\": \"Biocatalysis Process Technology License and Cooperation Agreement\\nLicensor: Beilan Bioengineering University; Licensee: Qingyue Pharmaceutical Manufacturing Co., Ltd.\\nArticle 1 Technology Definition. The licensed technology includes engineered enzyme strains, enzyme immobilization carriers, reactor control methods, and the patent applications CN202480123456.7 and PCT\u002FCN2024\u002F012345 listed in Schedule 1, for continuous enzymatic production of chiral alcohols. Licensed patents include divisions, continuations, foreign family members, and granted patents of the above applications.\\nArticle 2 Materials and Support. The licensor shall, within 45 days after effectiveness, deliver strain deposit certificates, DNA sequence information, fermentation formulations, immobilization operating procedures, reactor control software specifications, and three batches of experimental data. Sequence information shall be provided through a controlled electronic data room, and strains shall be shipped through compliant cold chain. The licensee shall complete document review within 20 days; the licensor shall provide on-site training and one process confirmation before the first commercial batch production.\\nArticle 3 License Scope. The licensor grants the licensee a non-exclusive license in Mainland China, South Korea, and Singapore to produce and sell the pharmaceutical intermediate L-hydroxybutyric acid, excluding food, feed, diagnostic reagents, and human therapeutic products. The licensee may sublicense to its controlled affiliates, but shall notify the licensor in advance and ensure the affiliates assume confidentiality and compliance obligations no less stringent than this agreement.\\nArticle 4 Manufacturing and Quality. The licensee may implement the licensed process only at the Suzhou and Busan production facilities listed in Schedule 2, shall follow GMP-related requirements, retain batch production records for at least seven years, and accept a quality audit by the licensor every two years. Product labels shall state that the product is produced by the licensed enzyme catalysis process. The licensee shall complete process validation within 18 months after effectiveness and achieve cumulative commercial sales of no less than 5,000 kg.\\nArticle 5 Improvements and Inventions. Improvements to the base enzyme strain owned by the licensor belong to the licensor; process scale-up and purification improvements independently completed by the licensee belong to the licensee. The licensee shall disclose improvements directly related to the licensed technology to the licensor before filing patent applications and shall grant the licensor a worldwide royalty-free right to use them for university research and teaching. Joint inventions shall be jointly owned by the parties, and patent application costs shall be shared 50%.\\nArticle 6 Infringement and Defense. Either party discovering third-party infringement shall notify the other within 15 days. The licensor is responsible for patent invalidation proceedings and core patent litigation; the licensee is responsible for trade secret enforcement related to its production facilities. Case costs shall be borne by the initiating party, and recovered amounts shall, after deducting reasonable costs, be distributed 40% to the licensor and 60% to the licensee. No settlement may restrict the other party from continuing to produce or use the licensed technology.\\nArticle 7 Export and Compliance. The parties may not transfer strains, sequences, process parameters, or software to countries, regions, or entities subject to United Nations, EU, U.S., or Chinese sanctions and export controls. Before exporting to South Korea or Singapore, the licensee shall obtain applicable biological material transport, export control, and customs approvals. The engineered enzyme strains are prohibited from being used for human in vivo administration or unapproved diagnostic uses.\\nArticle 8 Economic Terms. The licensee shall pay a signing fee of RMB 1.2 million and a 4% royalty on net sales of licensed products; upon reaching cumulative sales of 1,000 kg, 3,000 kg, and 5,000 kg, milestone payments of RMB 300,000, RMB 500,000, and RMB 800,000 respectively shall be paid. The licensee shall submit semi-annual reports and pay within 45 days after the period ends, and the licensor may audit once every 18 months.\", \"improvements\": \"{\\\"improvement_definition\\\": \\\"Upgrades, derivatives, or improvements such as base enzyme strain variants, process scale-up, purification, immobilization efficiency, reactor control, and yield optimization.\\\", \\\"ownership\\\": \\\"Improvements to the base enzyme strain owned by the licensor belong to the licensor; process scale-up and purification improvements independently completed by the licensee belong to the licensee; joint inventions are jointly owned by the parties.\\\", \\\"disclosure_obligation\\\": \\\"The licensee shall disclose improvements directly related to the licensed technology before filing patent applications; joint inventions shall be promptly notified and filing strategies discussed.\\\", \\\"license_back\\\": \\\"The licensee grants the licensor a worldwide, royalty-free right to use the improvements for university research and teaching, but not for the licensor's commercial production.\\\", \\\"invention_assignment\\\": \\\"Joint inventions are jointly owned by the parties, and patent application costs are shared 50%; either party assigning its shared rights shall notify the other party in advance.\\\"}\", \"document_type\": \"Technology License and Cooperation Agreement\", \"export_control\": \"{\\\"controlled_destinations\\\": [\\\"Countries, regions, or entities subject to United Nations sanctions\\\", \\\"Countries, regions, or entities subject to EU sanctions or export controls\\\", \\\"Countries, regions, or entities subject to U.S. sanctions or export controls\\\", \\\"Countries, regions, or entities subject to Chinese export controls\\\"], \\\"compliance_obligations\\\": \\\"The parties shall comply with biological material transport, export control, customs, sanctions, and technology transfer regulations, and implement access controls for strains, sequences, and process software.\\\", \\\"required_approvals\\\": \\\"Before exporting to South Korea or Singapore, the licensee shall obtain applicable biological material transport approvals, export control licenses, and customs approvals.\\\", \\\"prohibited_transactions\\\": \\\"It is prohibited to transfer strains, sequences, process parameters, and software to sanctioned or export-controlled entities, and to use engineered enzyme strains for human in vivo administration or unapproved diagnostic uses.\\\"}\", \"clause_evidence\": \"[{\\\"clause_topic\\\": \\\"Licensed technology and patent definition\\\", \\\"quote\\\": \\\"The licensed technology includes engineered enzyme strains, enzyme immobilization carriers, reactor control methods, and the patent applications CN202480123456.7 and PCT\u002FCN2024\u002F012345 listed in Schedule 1, for continuous enzymatic production of chiral alcohols.\\\", \\\"source_location\\\": \\\"Article 1 Technology Definition\\\", \\\"relevance\\\": \\\"Identifies the licensed technology composition, patent application identifiers, and process technology scope.\\\"}, {\\\"clause_topic\\\": \\\"Field and territory restrictions\\\", \\\"quote\\\": \\\"The licensor grants the licensee a non-exclusive license in Mainland China, South Korea, and Singapore to produce and sell the pharmaceutical intermediate L-hydroxybutyric acid, excluding food, feed, diagnostic reagents, and human therapeutic products.\\\", \\\"source_location\\\": \\\"Article 3 License Scope\\\", \\\"relevance\\\": \\\"States the license nature, territory, application field, and excluded uses.\\\"}, {\\\"clause_topic\\\": \\\"Manufacturing obligations and minimum commitment\\\", \\\"quote\\\": \\\"The licensee shall complete process validation within 18 months after effectiveness and achieve cumulative commercial sales of no less than 5,000 kg.\\\", \\\"source_location\\\": \\\"Article 4 Manufacturing and Quality\\\", \\\"relevance\\\": \\\"Supports retrieval conclusions on the process validation deadline and minimum commercialization sales target.\\\"}, {\\\"clause_topic\\\": \\\"Ownership of improvements\\\", \\\"quote\\\": \\\"Improvements to the base enzyme strain owned by the licensor belong to the licensor; process scale-up and purification improvements independently completed by the licensee belong to the licensee.\\\", \\\"source_location\\\": \\\"Article 5 Improvements and Inventions\\\", \\\"relevance\\\": \\\"Clarifies the distinction in ownership between base enzyme strain improvements and licensee process improvements.\\\"}, {\\\"clause_topic\\\": \\\"Export and use restrictions\\\", \\\"quote\\\": \\\"The parties may not transfer strains, sequences, process parameters, or software to countries, regions, or entities subject to United Nations, EU, U.S., or Chinese sanctions and export controls.\\\", \\\"source_location\\\": \\\"Article 7 Export and Compliance\\\", \\\"relevance\\\": \\\"Supports determination of controlled transfers and prohibited transactions for biological materials, sequences, and process software.\\\"}]\", \"financial_terms\": \"{\\\"royalty_basis\\\": \\\"Net sales of licensed products in the licensed territory, i.e., sales revenue after deducting discounts, returns, taxes, and freight.\\\", \\\"royalty_rate\\\": \\\"A 4% royalty on net sales of licensed products.\\\", \\\"milestone_or_lump_sum\\\": \\\"A signing fee of RMB 1.2 million; upon cumulative sales reaching 1,000 kg, 3,000 kg, and 5,000 kg, milestone payments of RMB 300,000, RMB 500,000, and RMB 800,000 respectively.\\\", \\\"reporting_and_audit\\\": \\\"Semi-annual sales and production reports; the licensor may audit once every 18 months, and the licensee shall retain batch production and sales records.\\\", \\\"payment_timing\\\": \\\"Reports and payments of royalties and triggered milestones shall be submitted within 45 days after the end of the reporting period.\\\"}\", \"key_obligations\": \"[{\\\"obligor\\\": \\\"Beilan Bioengineering University\\\", \\\"obligation\\\": \\\"Deliver strains, sequences, fermentation and immobilization materials, and provide on-site training and process confirmation.\\\", \\\"deadline\\\": \\\"Materials delivered within 45 days after the agreement takes effect; support completed before the first commercial batch production.\\\", \\\"trigger\\\": \\\"Agreement effectiveness and preparation for the first commercial batch production.\\\", \\\"consequence\\\": \\\"If delivery is delayed or materials are incomplete, the licensee may require remediation and extend the relevant validation deadlines.\\\"}, {\\\"obligor\\\": \\\"Qingyue Pharmaceutical Manufacturing Co., Ltd.\\\", \\\"obligation\\\": \\\"Implement the process only at the designated Suzhou and Busan facilities, comply with GMP requirements, and retain batch records.\\\", \\\"deadline\\\": \\\"Continuous performance during the agreement term, with records retained for at least seven years.\\\", \\\"trigger\\\": \\\"Starting pilot testing, process validation, or commercial production.\\\", \\\"consequence\\\": \\\"Production at unapproved facilities or violation of quality requirements may lead to suspension of production and termination of the license.\\\"}, {\\\"obligor\\\": \\\"Qingyue Pharmaceutical Manufacturing Co., Ltd.\\\", \\\"obligation\\\": \\\"Complete process validation within 18 months and achieve cumulative commercial sales of no less than 5,000 kg.\\\", \\\"deadline\\\": \\\"Within 18 months after the agreement takes effect.\\\", \\\"trigger\\\": \\\"Agreement effectiveness and commencement of commercialization preparation.\\\", \\\"consequence\\\": \\\"If not completed, the licensor may require rectification of the commercialization plan and suspend new territory expansion.\\\"}, {\\\"obligor\\\": \\\"Qingyue Pharmaceutical Manufacturing Co., Ltd.\\\", \\\"obligation\\\": \\\"Pay a 4% royalty on net sales and submit semi-annual reports.\\\", \\\"deadline\\\": \\\"Within 45 days after the end of each reporting period.\\\", \\\"trigger\\\": \\\"Sales of licensed products or achievement of milestones.\\\", \\\"consequence\\\": \\\"Late reporting or payment constitutes breach, and the licensor may audit and require supplementary payment and interest.\\\"}, {\\\"obligor\\\": \\\"Both parties\\\", \\\"obligation\\\": \\\"Enforce export control and use restrictions on strains, sequences, and process materials.\\\", \\\"deadline\\\": \\\"Before any export, re-export, transfer, or disclosure.\\\", \\\"trigger\\\": \\\"Intended transfer of controlled technical materials abroad or to third parties.\\\", \\\"consequence\\\": \\\"Unapproved transfers are material breaches and may lead to suspension or termination of the license and compliance liability.\\\"}]\", \"licensed_rights\": \"{\\\"grant_type\\\": \\\"Non-exclusive License\\\", \\\"manufacturing_rights\\\": \\\"The licensee may implement the licensed process and manufacture licensed products at the Suzhou and Busan production facilities listed in Schedule 2.\\\", \\\"use_rights\\\": \\\"May use the engineered enzyme strains, immobilization carriers, reactor control methods, and related technical secrets in the field of producing the pharmaceutical intermediate L-hydroxybutyric acid.\\\", \\\"sales_rights\\\": \\\"May sell licensed products in Mainland China, South Korea, and Singapore; customers and uses must comply with the pharmaceutical intermediate field restrictions and applicable regulations.\\\", \\\"sublicensing_rights\\\": \\\"May sublicense to controlled affiliates, but shall notify the licensor in advance and require affiliates to assume confidentiality and compliance obligations no less stringent than this agreement.\\\", \\\"reservation_of_rights\\\": \\\"The licensor reserves rights for university research, teaching, patent maintenance, and practice or licensing in excluded fields.\\\"}\", \"document_summary\": \"This is a non-exclusive license granted by Beilan Bioengineering University to Qingyue Pharmaceutical Manufacturing Co., Ltd. for a continuous enzymatic process for chiral alcohols. The license covers engineered enzyme strains, immobilization carriers, reactor control methods, and related patent applications, with territories including Mainland China, South Korea, and Singapore, and the application field limited to pharmaceutical intermediate production. The agreement provides for delivery of strains and technical materials, GMP quality requirements, designated production facilities, process validation, and minimum commercialization targets, and addresses improvements to base enzyme strains, process improvements, patent enforcement, biological material export, and tiered milestone payments.\", \"retrieval_keywords\": \"[\\\"engineered enzyme strain technology license\\\", \\\"continuous enzymatic process\\\", \\\"L-hydroxybutyric acid pharmaceutical intermediate\\\", \\\"non-exclusive patent license\\\", \\\"strain and DNA sequence delivery\\\", \\\"GMP production facility restrictions\\\", \\\"ownership of process improvements\\\", \\\"university research grant-back license\\\", \\\"biological material export control\\\", \\\"tiered milestone payments\\\", \\\"allocation of patent infringement costs\\\"]\", \"licensed_patent_scope\": \"{\\\"scope_definition\\\": \\\"The licensed technology includes engineered enzyme strains, enzyme immobilization carriers, reactor control methods, and related software specifications for continuous enzymatic production of chiral alcohols; licensed patents include the listed patent applications, their divisions, continuations, foreign family members, and granted patents.\\\", \\\"patent_identifiers\\\": [\\\"CN202480123456.7\\\", \\\"PCT\u002FCN2024\u002F012345\\\", \\\"divisions and foreign family members of the above applications\\\"], \\\"covered_technology\\\": \\\"Engineered enzyme strains, enzyme immobilization carriers, continuous enzymatic reactor control, fermentation and purification processes, and process parameters for producing L-hydroxybutyric acid.\\\", \\\"included_rights\\\": \\\"Includes patent practice rights to implement the process, manufacture, and sell licensed products within the licensed territory and limited application field, and rights to use related technical secrets.\\\", \\\"exclusions\\\": \\\"Excludes food, feed, diagnostic reagents, and human therapeutic products; engineered enzyme strains may not be used for human in vivo administration or unapproved diagnostic uses; the process may not be implemented at facilities other than those in Schedule 2.\\\", \\\"status_and_maintenance\\\": \\\"The licensor is responsible for prosecution, maintenance, and management of core patent claims of the licensed patent applications and shall notify the licensee of material office actions, grants, or abandonment decisions.\\\"}\", \"manufacturing_sales_terms\": \"{\\\"manufacturing_obligations\\\": \\\"The process may be implemented only at the Suzhou and Busan facilities listed in Schedule 2, following GMP-related requirements and retaining batch production records for at least seven years.\\\", \\\"quality_control\\\": \\\"The licensee shall complete process validation; the licensor may conduct a quality audit every two years; non-conforming batches may not be sold or diverted to unapproved uses.\\\", \\\"sales_obligations\\\": \\\"The licensee shall complete process validation within 18 months after effectiveness and achieve cumulative commercial sales of no less than 5,000 kg.\\\", \\\"marking_and_notice\\\": \\\"Licensed product labels shall state that the product is produced by the licensed enzyme catalysis process, and batch and process traceability information shall be retained in accordance with applicable regulations.\\\", \\\"minimum_commitments\\\": \\\"Cumulative commercial sales target of 5,000 kg within 18 months; if not completed, the licensor may require an improved commercialization plan and suspend new territory expansion.\\\"}\", \"technical_material_delivery\": \"{\\\"materials\\\": [\\\"Strain deposit certificates\\\", \\\"DNA sequence information\\\", \\\"Fermentation formulations\\\", \\\"Immobilization operating procedures\\\", \\\"Reactor control software specifications\\\", \\\"Three batches of experimental data\\\"], \\\"delivery_deadline\\\": \\\"Delivered within 45 days after the agreement takes effect; on-site training and one process confirmation completed before the first commercial batch production.\\\", \\\"delivery_format\\\": \\\"Sequence information provided through a controlled electronic data room, strains shipped through compliant cold chain, and other materials delivered as controlled electronic files.\\\", \\\"acceptance_and_support\\\": \\\"The licensee shall complete document review within 20 days; the licensor shall provide on-site training and assist with one process confirmation before the first commercial batch production.\\\", \\\"confidentiality_requirements\\\": \\\"Strains, sequences, process parameters, and software specifications may be accessed only by authorized personnel and may not be copied, disclosed to unauthorized entities, or used outside the limited field.\\\"}\", \"infringement_and_enforcement\": \"{\\\"infringement_notification\\\": \\\"Upon discovering third-party infringement or suspected illegal use of strains, sequences, or process secrets, the discovering party shall notify the other party within 15 days.\\\", \\\"enforcement_rights\\\": \\\"The licensor is responsible for patent invalidation proceedings and core patent litigation; the licensee is responsible for trade secret enforcement related to its production facilities.\\\", \\\"cost_and_recovery\\\": \\\"Case costs are borne by the initiating party; recovered amounts, after deducting reasonable costs, are distributed 40% to the licensor and 60% to the licensee.\\\", \\\"cooperation\\\": \\\"The parties shall provide samples, batch records, technical experts, patent documents, and necessary litigation authorization.\\\", \\\"settlement_control\\\": \\\"No settlement may restrict the other party from continuing to produce or use the licensed technology, or acknowledge invalidity of the other party's patent or trade secret rights.\\\"}\", \"field_and_territory_restrictions\": \"{\\\"application_fields\\\": [\\\"Production of the pharmaceutical intermediate L-hydroxybutyric acid\\\", \\\"Commercialization of continuous enzymatic process\\\"], \\\"territories\\\": [\\\"Mainland China\\\", \\\"South Korea\\\", \\\"Singapore\\\"], \\\"customer_restrictions\\\": \\\"May not provide related materials to customers intending to use the engineered enzyme strains for human in vivo administration, unapproved diagnostics, or other excluded uses.\\\", \\\"channel_restrictions\\\": \\\"No specific sales channels are set, but sales and biological material transport must comply with pharmaceutical, customs, and export control requirements.\\\", \\\"exclusivity\\\": \\\"The license is non-exclusive; the licensor reserves the right to practice itself and license to other entities.\\\"}\"}","[{\"party_name\": \"Beilan Bioengineering University\", \"party_role\": \"Licensor\", \"entity_type\": \"University\", \"jurisdiction\": \"Mainland China\"}, {\"party_name\": \"Qingyue Pharmaceutical Manufacturing Co., Ltd.\", \"party_role\": \"Licensee\", \"entity_type\": \"Company\", \"jurisdiction\": \"Mainland China\"}]","Biocatalysis Process Technology License and Cooperation Agreement\nLicensor: Beilan Bioengineering University; Licensee: Qingyue Pharmaceutical Manufacturing Co., Ltd.\nArticle 1 Technology Definition. The licensed technology includes engineered enzyme strains, enzyme immobilization carriers, reactor control methods, and the patent applications CN202480123456.7 and PCT\u002FCN2024\u002F012345 listed in Schedule 1, for continuous enzymatic production of chiral alcohols. Licensed patents include divisions, continuations, foreign family members, and granted patents of the above applications.\nArticle 2 Materials and Support. The licensor shall, within 45 days after effectiveness, deliver strain deposit certificates, DNA sequence information, fermentation formulations, immobilization operating procedures, reactor control software specifications, and three batches of experimental data. Sequence information shall be provided through a controlled electronic data room, and strains shall be shipped through compliant cold chain. The licensee shall complete document review within 20 days; the licensor shall provide on-site training and one process confirmation before the first commercial batch production.\nArticle 3 License Scope. The licensor grants the licensee a non-exclusive license in Mainland China, South Korea, and Singapore to produce and sell the pharmaceutical intermediate L-hydroxybutyric acid, excluding food, feed, diagnostic reagents, and human therapeutic products. The licensee may sublicense to its controlled affiliates, but shall notify the licensor in advance and ensure the affiliates assume confidentiality and compliance obligations no less stringent than this agreement.\nArticle 4 Manufacturing and Quality. The licensee may implement the licensed process only at the Suzhou and Busan production facilities listed in Schedule 2, shall follow GMP-related requirements, retain batch production records for at least seven years, and accept a quality audit by the licensor every two years. Product labels shall state that the product is produced by the licensed enzyme catalysis process. The licensee shall complete process validation within 18 months after effectiveness and achieve cumulative commercial sales of no less than 5,000 kg.\nArticle 5 Improvements and Inventions. Improvements to the base enzyme strain owned by the licensor belong to the licensor; process scale-up and purification improvements independently completed by the licensee belong to the licensee. The licensee shall disclose improvements directly related to the licensed technology to the licensor before filing patent applications and shall grant the licensor a worldwide royalty-free right to use them for university research and teaching. Joint inventions shall be jointly owned by the parties, and patent application costs shall be shared 50%.\nArticle 6 Infringement and Defense. Either party discovering third-party infringement shall notify the other within 15 days. The licensor is responsible for patent invalidation proceedings and core patent litigation; the licensee is responsible for trade secret enforcement related to its production facilities. Case costs shall be borne by the initiating party, and recovered amounts shall, after deducting reasonable costs, be distributed 40% to the licensor and 60% to the licensee. No settlement may restrict the other party from continuing to produce or use the licensed technology.\nArticle 7 Export and Compliance. The parties may not transfer strains, sequences, process parameters, or software to countries, regions, or entities subject to United Nations, EU, U.S., or Chinese sanctions and export controls. Before exporting to South Korea or Singapore, the licensee shall obtain applicable biological material transport, export control, and customs approvals. The engineered enzyme strains are prohibited from being used for human in vivo administration or unapproved diagnostic uses.\nArticle 8 Economic Terms. The licensee shall pay a signing fee of RMB 1.2 million and a 4% royalty on net sales of licensed products; upon reaching cumulative sales of 1,000 kg, 3,000 kg, and 5,000 kg, milestone payments of RMB 300,000, RMB 500,000, and RMB 800,000 respectively shall be paid. The licensee shall submit semi-annual reports and pay within 45 days after the period ends, and the licensor may audit once every 18 months.","{\"improvement_definition\": \"Upgrades, derivatives, or improvements such as base enzyme strain variants, process scale-up, purification, immobilization efficiency, reactor control, and yield optimization.\", \"ownership\": \"Improvements to the base enzyme strain owned by the licensor belong to the licensor; process scale-up and purification improvements independently completed by the licensee belong to the licensee; joint inventions are jointly owned by the parties.\", \"disclosure_obligation\": \"The licensee shall disclose improvements directly related to the licensed technology before filing patent applications; joint inventions shall be promptly notified and filing strategies discussed.\", \"license_back\": \"The licensee grants the licensor a worldwide, royalty-free right to use the improvements for university research and teaching, but not for the licensor's commercial production.\", \"invention_assignment\": \"Joint inventions are jointly owned by the parties, and patent application costs are shared 50%; either party assigning its shared rights shall notify the other party in advance.\"}","Technology License and Cooperation Agreement","{\"controlled_destinations\": [\"Countries, regions, or entities subject to United Nations sanctions\", \"Countries, regions, or entities subject to EU sanctions or export controls\", \"Countries, regions, or entities subject to U.S. sanctions or export controls\", \"Countries, regions, or entities subject to Chinese export controls\"], \"compliance_obligations\": \"The parties shall comply with biological material transport, export control, customs, sanctions, and technology transfer regulations, and implement access controls for strains, sequences, and process software.\", \"required_approvals\": \"Before exporting to South Korea or Singapore, the licensee shall obtain applicable biological material transport approvals, export control licenses, and customs approvals.\", \"prohibited_transactions\": \"It is prohibited to transfer strains, sequences, process parameters, and software to sanctioned or export-controlled entities, and to use engineered enzyme strains for human in vivo administration or unapproved diagnostic uses.\"}","[{\"clause_topic\": \"Licensed technology and patent definition\", \"quote\": \"The licensed technology includes engineered enzyme strains, enzyme immobilization carriers, reactor control methods, and the patent applications CN202480123456.7 and PCT\u002FCN2024\u002F012345 listed in Schedule 1, for continuous enzymatic production of chiral alcohols.\", \"source_location\": \"Article 1 Technology Definition\", \"relevance\": \"Identifies the licensed technology composition, patent application identifiers, and process technology scope.\"}, {\"clause_topic\": \"Field and territory restrictions\", \"quote\": \"The licensor grants the licensee a non-exclusive license in Mainland China, South Korea, and Singapore to produce and sell the pharmaceutical intermediate L-hydroxybutyric acid, excluding food, feed, diagnostic reagents, and human therapeutic products.\", \"source_location\": \"Article 3 License Scope\", \"relevance\": \"States the license nature, territory, application field, and excluded uses.\"}, {\"clause_topic\": \"Manufacturing obligations and minimum commitment\", \"quote\": \"The licensee shall complete process validation within 18 months after effectiveness and achieve cumulative commercial sales of no less than 5,000 kg.\", \"source_location\": \"Article 4 Manufacturing and Quality\", \"relevance\": \"Supports retrieval conclusions on the process validation deadline and minimum commercialization sales target.\"}, {\"clause_topic\": \"Ownership of improvements\", \"quote\": \"Improvements to the base enzyme strain owned by the licensor belong to the licensor; process scale-up and purification improvements independently completed by the licensee belong to the licensee.\", \"source_location\": \"Article 5 Improvements and Inventions\", \"relevance\": \"Clarifies the distinction in ownership between base enzyme strain improvements and licensee process improvements.\"}, {\"clause_topic\": \"Export and use restrictions\", \"quote\": \"The parties may not transfer strains, sequences, process parameters, or software to countries, regions, or entities subject to United Nations, EU, U.S., or Chinese sanctions and export controls.\", \"source_location\": \"Article 7 Export and Compliance\", \"relevance\": \"Supports determination of controlled transfers and prohibited transactions for biological materials, sequences, and process software.\"}]","{\"royalty_basis\": \"Net sales of licensed products in the licensed territory, i.e., sales revenue after deducting discounts, returns, taxes, and freight.\", \"royalty_rate\": \"A 4% royalty on net sales of licensed products.\", \"milestone_or_lump_sum\": \"A signing fee of RMB 1.2 million; upon cumulative sales reaching 1,000 kg, 3,000 kg, and 5,000 kg, milestone payments of RMB 300,000, RMB 500,000, and RMB 800,000 respectively.\", \"reporting_and_audit\": \"Semi-annual sales and production reports; the licensor may audit once every 18 months, and the licensee shall retain batch production and sales records.\", \"payment_timing\": \"Reports and payments of royalties and triggered milestones shall be submitted within 45 days after the end of the reporting period.\"}","[{\"obligor\": \"Beilan Bioengineering University\", \"obligation\": \"Deliver strains, sequences, fermentation and immobilization materials, and provide on-site training and process confirmation.\", \"deadline\": \"Materials delivered within 45 days after the agreement takes effect; support completed before the first commercial batch production.\", \"trigger\": \"Agreement effectiveness and preparation for the first commercial batch production.\", \"consequence\": \"If delivery is delayed or materials are incomplete, the licensee may require remediation and extend the relevant validation deadlines.\"}, {\"obligor\": \"Qingyue Pharmaceutical Manufacturing Co., Ltd.\", \"obligation\": \"Implement the process only at the designated Suzhou and Busan facilities, comply with GMP requirements, and retain batch records.\", \"deadline\": \"Continuous performance during the agreement term, with records retained for at least seven years.\", \"trigger\": \"Starting pilot testing, process validation, or commercial production.\", \"consequence\": \"Production at unapproved facilities or violation of quality requirements may lead to suspension of production and termination of the license.\"}, {\"obligor\": \"Qingyue Pharmaceutical Manufacturing Co., Ltd.\", \"obligation\": \"Complete process validation within 18 months and achieve cumulative commercial sales of no less than 5,000 kg.\", \"deadline\": \"Within 18 months after the agreement takes effect.\", \"trigger\": \"Agreement effectiveness and commencement of commercialization preparation.\", \"consequence\": \"If not completed, the licensor may require rectification of the commercialization plan and suspend new territory expansion.\"}, {\"obligor\": \"Qingyue Pharmaceutical Manufacturing Co., Ltd.\", \"obligation\": \"Pay a 4% royalty on net sales and submit semi-annual reports.\", \"deadline\": \"Within 45 days after the end of each reporting period.\", \"trigger\": \"Sales of licensed products or achievement of milestones.\", \"consequence\": \"Late reporting or payment constitutes breach, and the licensor may audit and require supplementary payment and interest.\"}, {\"obligor\": \"Both parties\", \"obligation\": \"Enforce export control and use restrictions on strains, sequences, and process materials.\", \"deadline\": \"Before any export, re-export, transfer, or disclosure.\", \"trigger\": \"Intended transfer of controlled technical materials abroad or to third parties.\", \"consequence\": \"Unapproved transfers are material breaches and may lead to suspension or termination of the license and compliance liability.\"}]","{\"grant_type\": \"Non-exclusive License\", \"manufacturing_rights\": \"The licensee may implement the licensed process and manufacture licensed products at the Suzhou and Busan production facilities listed in Schedule 2.\", \"use_rights\": \"May use the engineered enzyme strains, immobilization carriers, reactor control methods, and related technical secrets in the field of producing the pharmaceutical intermediate L-hydroxybutyric acid.\", \"sales_rights\": \"May sell licensed products in Mainland China, South Korea, and Singapore; customers and uses must comply with the pharmaceutical intermediate field restrictions and applicable regulations.\", \"sublicensing_rights\": \"May sublicense to controlled affiliates, but shall notify the licensor in advance and require affiliates to assume confidentiality and compliance obligations no less stringent than this agreement.\", \"reservation_of_rights\": \"The licensor reserves rights for university research, teaching, patent maintenance, and practice or licensing in excluded fields.\"}","This is a non-exclusive license granted by Beilan Bioengineering University to Qingyue Pharmaceutical Manufacturing Co., Ltd. for a continuous enzymatic process for chiral alcohols. The license covers engineered enzyme strains, immobilization carriers, reactor control methods, and related patent applications, with territories including Mainland China, South Korea, and Singapore, and the application field limited to pharmaceutical intermediate production. The agreement provides for delivery of strains and technical materials, GMP quality requirements, designated production facilities, process validation, and minimum commercialization targets, and addresses improvements to base enzyme strains, process improvements, patent enforcement, biological material export, and tiered milestone payments.","[\"engineered enzyme strain technology license\", \"continuous enzymatic process\", \"L-hydroxybutyric acid pharmaceutical intermediate\", \"non-exclusive patent license\", \"strain and DNA sequence delivery\", \"GMP production facility restrictions\", \"ownership of process improvements\", \"university research grant-back license\", \"biological material export control\", \"tiered milestone payments\", \"allocation of patent infringement costs\"]","{\"scope_definition\": \"The licensed technology includes engineered enzyme strains, enzyme immobilization carriers, reactor control methods, and related software specifications for continuous enzymatic production of chiral alcohols; licensed patents include the listed patent applications, their divisions, continuations, foreign family members, and granted patents.\", \"patent_identifiers\": [\"CN202480123456.7\", \"PCT\u002FCN2024\u002F012345\", \"divisions and foreign family members of the above applications\"], \"covered_technology\": \"Engineered enzyme strains, enzyme immobilization carriers, continuous enzymatic reactor control, fermentation and purification processes, and process parameters for producing L-hydroxybutyric acid.\", \"included_rights\": \"Includes patent practice rights to implement the process, manufacture, and sell licensed products within the licensed territory and limited application field, and rights to use related technical secrets.\", \"exclusions\": \"Excludes food, feed, diagnostic reagents, and human therapeutic products; engineered enzyme strains may not be used for human in vivo administration or unapproved diagnostic uses; the process may not be implemented at facilities other than those in Schedule 2.\", \"status_and_maintenance\": \"The licensor is responsible for prosecution, maintenance, and management of core patent claims of the licensed patent applications and shall notify the licensee of material office actions, grants, or abandonment decisions.\"}","{\"manufacturing_obligations\": \"The process may be implemented only at the Suzhou and Busan facilities listed in Schedule 2, following GMP-related requirements and retaining batch production records for at least seven years.\", \"quality_control\": \"The licensee shall complete process validation; the licensor may conduct a quality audit every two years; non-conforming batches may not be sold or diverted to unapproved uses.\", \"sales_obligations\": \"The licensee shall complete process validation within 18 months after effectiveness and achieve cumulative commercial sales of no less than 5,000 kg.\", \"marking_and_notice\": \"Licensed product labels shall state that the product is produced by the licensed enzyme catalysis process, and batch and process traceability information shall be retained in accordance with applicable regulations.\", \"minimum_commitments\": \"Cumulative commercial sales target of 5,000 kg within 18 months; if not completed, the licensor may require an improved commercialization plan and suspend new territory expansion.\"}","{\"materials\": [\"Strain deposit certificates\", \"DNA sequence information\", \"Fermentation formulations\", \"Immobilization operating procedures\", \"Reactor control software specifications\", \"Three batches of experimental data\"], \"delivery_deadline\": \"Delivered within 45 days after the agreement takes effect; on-site training and one process confirmation completed before the first commercial batch production.\", \"delivery_format\": \"Sequence information provided through a controlled electronic data room, strains shipped through compliant cold chain, and other materials delivered as controlled electronic files.\", \"acceptance_and_support\": \"The licensee shall complete document review within 20 days; the licensor shall provide on-site training and assist with one process confirmation before the first commercial batch production.\", \"confidentiality_requirements\": \"Strains, sequences, process parameters, and software specifications may be accessed only by authorized personnel and may not be copied, disclosed to unauthorized entities, or used outside the limited field.\"}","{\"infringement_notification\": \"Upon discovering third-party infringement or suspected illegal use of strains, sequences, or process secrets, the discovering party shall notify the other party within 15 days.\", \"enforcement_rights\": \"The licensor is responsible for patent invalidation proceedings and core patent litigation; the licensee is responsible for trade secret enforcement related to its production facilities.\", \"cost_and_recovery\": \"Case costs are borne by the initiating party; recovered amounts, after deducting reasonable costs, are distributed 40% to the licensor and 60% to the licensee.\", \"cooperation\": \"The parties shall provide samples, batch records, technical experts, patent documents, and necessary litigation authorization.\", \"settlement_control\": \"No settlement may restrict the other party from continuing to produce or use the licensed technology, or acknowledge invalidity of the other party's patent or trade secret rights.\"}","{\"application_fields\": [\"Production of the pharmaceutical intermediate L-hydroxybutyric acid\", \"Commercialization of continuous enzymatic process\"], \"territories\": [\"Mainland China\", \"South Korea\", \"Singapore\"], \"customer_restrictions\": \"May not provide related materials to customers intending to use the engineered enzyme strains for human in vivo administration, unapproved diagnostics, or other excluded uses.\", \"channel_restrictions\": \"No specific sales channels are set, but sales and biological material transport must comply with pharmaceutical, customs, and export control requirements.\", \"exclusivity\": \"The license is non-exclusive; the licensor reserves the right to practice itself and license to other entities.\"}",{"id":734,"relate_table":690,"relate_id":735,"file_size":572,"file_name":736,"path":8,"duration":572,"cate":483,"file_format":693,"audio_rate":8,"audio_channel":522,"audio_bit_depth":522,"quality":8,"annotation":737,"cate_name":695,"parties":738,"source_text":739,"improvements":740,"document_type":741,"export_control":742,"clause_evidence":743,"financial_terms":744,"key_obligations":745,"licensed_rights":746,"document_summary":747,"retrieval_keywords":748,"licensed_patent_scope":749,"manufacturing_sales_terms":750,"technical_material_delivery":751,"infringement_and_enforcement":752,"field_and_territory_restrictions":753},15199,1541706231,"样例_1.json","{\"parties\": \"[{\\\"party_name\\\": \\\"Chengming Energy Research Institute\\\", \\\"party_role\\\": \\\"Licensor\\\", \\\"entity_type\\\": \\\"Research Institution\\\", \\\"jurisdiction\\\": \\\"Mainland China\\\"}, {\\\"party_name\\\": \\\"Yuancen Energy Storage Technology Co., Ltd.\\\", \\\"party_role\\\": \\\"Licensee\\\", \\\"entity_type\\\": \\\"Company\\\", \\\"jurisdiction\\\": \\\"Mainland China\\\"}]\", \"source_text\": \"Patent and Technology License Agreement\\nLicensor: Chengming Energy Research Institute; Licensee: Yuancen Energy Storage Technology Co., Ltd.\\nArticle 1 Licensed Technology. The licensed patents include patents and patent applications owned or controlled by the licensor relating to manganese-based cathode surface coatings for aqueous zinc-ion batteries, specifically including CN209876543A, CN214567890B, and their family applications within the licensed territory. The licensed technology also includes the coating formulations, slurry preparation parameters, and heat treatment processes listed in Appendix A.\\nArticle 2 Delivery of Materials. The licensor shall, within 30 days after the agreement takes effect, deliver the coating formulations, process flow diagrams, quality inspection methods, trial samples, and test reports, and shall provide two remote technical training sessions before the licensee's first pilot test. The materials shall be delivered as Chinese electronic files and encrypted download links. The licensee shall complete acceptance within 15 days after receipt; if the materials do not meet the indicators in Appendix B, the licensor shall remedy them within 10 working days.\\nArticle 3 Licensed Rights. The licensor grants the licensee an exclusive license to manufacture, use, offer for sale, sell, and import licensed products in Mainland China, but only for stationary energy storage batteries and their battery packs. The licensee may not sublicense the licensed technology to third parties, but may entrust manufacturing to contract manufacturers approved in writing by the licensor. The licensor reserves rights for research, teaching, and non-commercial testing.\\nArticle 4 Field and Territory. The licensed field is stationary energy storage, excluding new energy vehicles, consumer electronics, and military uses; the licensed territory is Mainland China, excluding Hong Kong, Macao, and Taiwan. The licensor shall not grant the same exclusive rights to third parties in the licensed field, but reserves the right to practice or license in the excluded fields.\\nArticle 5 Manufacturing and Sales. The licensee shall produce licensed products in factories compliant with ISO 9001, follow the process windows provided by the licensor, and accept one quality audit per year. Product labels shall indicate the licensed patent numbers. The licensee shall sell no fewer than 20,000 battery packs in the second full year after effectiveness; if the minimum commitment is not met and no force majeure applies, the licensor may convert the exclusive license into a non-exclusive license.\\nArticle 6 Improvements. Technical improvements made by the licensee in coating thickness control and low-temperature cycle performance shall belong to the licensee, but the licensee shall notify the licensor in writing 30 days before filing a patent application or public disclosure and shall grant the licensor a worldwide, non-exclusive, royalty-free license for internal research and non-commercial use. Improvements completed jointly by the parties shall be jointly owned in proportion to contributions.\\nArticle 7 Infringement. If either party discovers that a third party infringes the licensed patents, it shall notify the other party within 10 days and provide evidence. The licensor has the right to decide whether to bring an action; if the licensor does not act, the licensee may bring an action after the licensor's written consent. The licensor shall bear the costs of the lead action and receive 60% of damages, and the licensee shall bear the remaining costs and receive 40% of damages. Without the other party's written consent, neither party may enter into a settlement that acknowledges patent invalidity or affects the other party's rights.\\nArticle 8 Export Compliance. Without obtaining applicable export licenses, the licensee may not export, re-export, or disclose the licensed technology to destinations restricted by U.S., EU, or Chinese export controls or to entities on sanctions lists. The parties shall comply with export control, customs, and anti-sanctions laws.\\nArticle 9 Fees. The licensee shall pay a non-refundable upfront fee of RMB 800,000; and shall pay a 3% royalty on net sales of licensed products in the licensed territory. Sales reports and payments shall be submitted within 30 days after the end of each quarter, and the licensor may audit once per year.\\nArticle 10 Confidentiality. The delivered materials shall be accessible only to the licensee and its employees and consultants bound by confidentiality obligations, and may not be copied or disclosed without the licensor's written consent.\", \"improvements\": \"{\\\"improvement_definition\\\": \\\"Upgrades, optimizations, and derivative technical improvements to coating thickness control, slurry stability, low-temperature cycle performance, or licensed process parameters.\\\", \\\"ownership\\\": \\\"Improvements independently completed by the licensee belong to the licensee; improvements jointly completed by the parties are jointly owned in proportion to actual technical contributions.\\\", \\\"disclosure_obligation\\\": \\\"The licensee shall notify the licensor in writing 30 days before filing a patent application or disclosing improvements and provide a technical summary sufficient for evaluation.\\\", \\\"license_back\\\": \\\"The licensee grants the licensor a worldwide, non-exclusive, royalty-free license for internal research and non-commercial use.\\\", \\\"invention_assignment\\\": \\\"Improvements jointly completed by the parties shall be jointly patented in proportion to shared ownership; neither party may separately assign its shared share without the other party's consent.\\\"}\", \"document_type\": \"Patent and Technology License Agreement\", \"export_control\": \"{\\\"controlled_destinations\\\": [\\\"Destinations subject to U.S. export control restrictions\\\", \\\"Destinations subject to EU sanctions or export control restrictions\\\", \\\"Destinations subject to Chinese export control restrictions\\\", \\\"Entities on applicable sanctions lists\\\"], \\\"compliance_obligations\\\": \\\"The parties shall comply with applicable export control, customs, sanctions, and anti-sanctions laws, and may not circumvent technology export restrictions through third parties.\\\", \\\"required_approvals\\\": \\\"Before exporting, re-exporting, or disclosing licensed technology abroad, applicable government export licenses and internal compliance approvals of both parties shall be obtained.\\\", \\\"prohibited_transactions\\\": \\\"It is prohibited to export, re-export, or disclose licensed technology to controlled destinations or sanctioned entities, and to conduct cross-border technology transfers without approval.\\\"}\", \"clause_evidence\": \"[{\\\"clause_topic\\\": \\\"Scope of licensed patents\\\", \\\"quote\\\": \\\"The licensed patents include patents and patent applications owned or controlled by the licensor relating to manganese-based cathode surface coatings for aqueous zinc-ion batteries, specifically including CN209876543A, CN214567890B, and their family applications within the licensed territory.\\\", \\\"source_location\\\": \\\"Article 1 Licensed Technology\\\", \\\"relevance\\\": \\\"Defines the licensed patents, patent identifiers, and family application scope, applicable for searching the objects covered by the licensed technology.\\\"}, {\\\"clause_topic\\\": \\\"Manufacturing and sales rights\\\", \\\"quote\\\": \\\"The licensor grants the licensee an exclusive license to manufacture, use, offer for sale, sell, and import licensed products in Mainland China, but only for stationary energy storage batteries and their battery packs.\\\", \\\"source_location\\\": \\\"Article 3 Licensed Rights\\\", \\\"relevance\\\": \\\"Directly states the license nature, commercialization rights, territory, and application field restrictions.\\\"}, {\\\"clause_topic\\\": \\\"Minimum commercialization commitment\\\", \\\"quote\\\": \\\"The licensee shall sell no fewer than 20,000 battery packs in the second full year after effectiveness; if the minimum commitment is not met and no force majeure applies, the licensor may convert the exclusive license into a non-exclusive license.\\\", \\\"source_location\\\": \\\"Article 5 Manufacturing and Sales\\\", \\\"relevance\\\": \\\"Reflects the minimum sales volume and change in exclusivity if not met, and is important evidence for commercialization obligation searches.\\\"}, {\\\"clause_topic\\\": \\\"Improvement technology\\\", \\\"quote\\\": \\\"Technical improvements made by the licensee in coating thickness control and low-temperature cycle performance shall belong to the licensee, but the licensee shall notify the licensor in writing 30 days before filing a patent application or public disclosure and shall grant the licensor a worldwide, non-exclusive, royalty-free license for internal research and non-commercial use.\\\", \\\"source_location\\\": \\\"Article 6 Improvements\\\", \\\"relevance\\\": \\\"Supports structured conclusions on ownership of improvements, disclosure deadline, and royalty-free grant-back license.\\\"}, {\\\"clause_topic\\\": \\\"Export restrictions\\\", \\\"quote\\\": \\\"Without obtaining applicable export licenses, the licensee may not export, re-export, or disclose the licensed technology to destinations restricted by U.S., EU, or Chinese export controls or to entities on sanctions lists.\\\", \\\"source_location\\\": \\\"Article 8 Export Compliance\\\", \\\"relevance\\\": \\\"Clarifies controlled destinations, approval requirements, and prohibited cross-border technology transactions.\\\"}]\", \"financial_terms\": \"{\\\"royalty_basis\\\": \\\"Net sales of licensed products in Mainland China, i.e., actual sales revenue after deducting discounts, returns, VAT, and freight.\\\", \\\"royalty_rate\\\": \\\"In addition to the upfront fee, a 3% royalty on net sales.\\\", \\\"milestone_or_lump_sum\\\": \\\"A non-refundable upfront fee of RMB 800,000 payable after the agreement takes effect; no additional milestone payments are stipulated.\\\", \\\"reporting_and_audit\\\": \\\"Sales reports and royalty payments shall be submitted within 30 days after the end of each quarter; the licensor may audit relevant books once per year, and if underreporting exceeds 5%, the licensee shall bear audit costs.\\\", \\\"payment_timing\\\": \\\"Reports and payments shall be completed within 30 days after the end of each quarter; overdue payments shall bear default interest as stipulated in the agreement.\\\"}\", \"key_obligations\": \"[{\\\"obligor\\\": \\\"Chengming Energy Research Institute\\\", \\\"obligation\\\": \\\"Deliver formulations, process documents, samples, and test reports, and provide two remote technical training sessions.\\\", \\\"deadline\\\": \\\"Within 30 days after the agreement takes effect; training completed before the first pilot test.\\\", \\\"trigger\\\": \\\"Agreement effectiveness and the licensee's first pilot test.\\\", \\\"consequence\\\": \\\"If materials are not delivered as required or are defective, the licensee may require remediation within 10 working days.\\\"}, {\\\"obligor\\\": \\\"Yuancen Energy Storage Technology Co., Ltd.\\\", \\\"obligation\\\": \\\"Manufacture and sell licensed products in the stationary energy storage field in Mainland China and comply with process and quality requirements.\\\", \\\"deadline\\\": \\\"Continuous performance during the agreement term.\\\", \\\"trigger\\\": \\\"Obtaining the license and starting pilot or commercial production.\\\", \\\"consequence\\\": \\\"Serious violation of field, territory, or quality restrictions may constitute breach and lead to termination of the license.\\\"}, {\\\"obligor\\\": \\\"Yuancen Energy Storage Technology Co., Ltd.\\\", \\\"obligation\\\": \\\"Sell no fewer than 20,000 battery packs per year starting from the second full year.\\\", \\\"deadline\\\": \\\"Verified at the end of each full year.\\\", \\\"trigger\\\": \\\"Entering the second full year after the agreement takes effect.\\\", \\\"consequence\\\": \\\"If not met without force majeure, the licensor may convert the exclusive license to a non-exclusive license.\\\"}, {\\\"obligor\\\": \\\"Both parties\\\", \\\"obligation\\\": \\\"Promptly notify, provide evidence, and cooperate in enforcement upon discovering third-party infringement.\\\", \\\"deadline\\\": \\\"Notify within 10 days after discovering infringement.\\\", \\\"trigger\\\": \\\"Discovery or reasonable suspicion of third-party infringement.\\\", \\\"consequence\\\": \\\"If delayed notice expands losses, the breaching party shall bear corresponding liability.\\\"}, {\\\"obligor\\\": \\\"Yuancen Energy Storage Technology Co., Ltd.\\\", \\\"obligation\\\": \\\"Obtain applicable approvals and comply with export controls before exporting, re-exporting, or disclosing technology.\\\", \\\"deadline\\\": \\\"Before the relevant cross-border activity occurs.\\\", \\\"trigger\\\": \\\"Intended transfer of technology or products abroad.\\\", \\\"consequence\\\": \\\"Transactions without approval constitute material breach, and the licensor may suspend materials and licensed rights.\\\"}]\", \"licensed_rights\": \"{\\\"grant_type\\\": \\\"Exclusive License\\\", \\\"manufacturing_rights\\\": \\\"The licensee may manufacture stationary energy storage batteries and battery packs in Mainland China, and may entrust manufacturing to contract manufacturers approved in writing by the licensor.\\\", \\\"use_rights\\\": \\\"May use the licensed technology in the stationary energy storage field for R&D, pilot testing, production, and non-export commercial applications.\\\", \\\"sales_rights\\\": \\\"May offer for sale, sell, and distribute licensed products in Mainland China, but may not sell or use them in excluded fields.\\\", \\\"sublicensing_rights\\\": \\\"In principle, no sublicensing; manufacturing may only be entrusted to contract manufacturers approved in writing by the licensor and subject to equivalent confidentiality obligations.\\\", \\\"reservation_of_rights\\\": \\\"The licensor reserves research, teaching, non-commercial testing, and the right to practice or license in excluded fields such as new energy vehicles, consumer electronics, and military.\\\"}\", \"document_summary\": \"This is an exclusive license granted by Chengming Energy Research Institute to Yuancen Energy Storage Technology Co., Ltd. for stationary energy storage battery coating technology in Mainland China. The license scope covers two patents and their family applications and includes formulations, processes, and testing materials; the licensee obtains rights to manufacture, use, sell, and import, but may not use the technology in new energy vehicles, consumer electronics, or military fields, and may not sublicense without consent. The agreement sets conditions for material delivery, quality audits, minimum sales volume, improvement grant-back, infringement cooperation, export control, and royalties calculated on net sales.\", \"retrieval_keywords\": \"[\\\"aqueous zinc-ion battery patent license\\\", \\\"manganese-based cathode coating technology\\\", \\\"stationary energy storage exclusive license\\\", \\\"Mainland China licensed territory\\\", \\\"minimum sales volume of licensed products\\\", \\\"technical material delivery and acceptance\\\", \\\"royalty-free grant-back of improvements\\\", \\\"allocation of third-party infringement litigation costs\\\", \\\"licensed patent marking\\\", \\\"export control and re-export\\\", \\\"3% royalty on net sales\\\"]\", \"licensed_patent_scope\": \"{\\\"scope_definition\\\": \\\"The licensed patents include patents, patent applications, and family applications within the licensed territory owned or controlled by the licensor relating to manganese-based cathode surface coatings for aqueous zinc-ion batteries, and extend to the formulations, slurry preparation parameters, and heat treatment processes listed in Appendix A.\\\", \\\"patent_identifiers\\\": [\\\"CN209876543A\\\", \\\"CN214567890B\\\", \\\"family applications within the licensed territory\\\"], \\\"covered_technology\\\": \\\"Manganese-based cathode surface coatings for aqueous zinc-ion batteries, coating slurry preparation, heat treatment processes, and their application in stationary energy storage batteries.\\\", \\\"included_rights\\\": \\\"Includes the right to practice by manufacturing, using, offering for sale, selling, and importing licensed products within the licensed territory and licensed field, and the right to use related technical materials for pilot testing and commercial production.\\\", \\\"exclusions\\\": \\\"Excludes new energy vehicles, consumer electronics, and military uses; excludes Hong Kong, Macao, and Taiwan; no sublicensing to third parties without the licensor's written consent.\\\", \\\"status_and_maintenance\\\": \\\"The licensor is responsible for maintaining the licensed patents and paying ordinary annual fees; if it intends to abandon or cease maintaining any licensed patent, it shall notify the licensee at least 60 days in advance, and the licensee may choose to maintain the relevant rights itself.\\\"}\", \"manufacturing_sales_terms\": \"{\\\"manufacturing_obligations\\\": \\\"The licensee shall manufacture in ISO 9001-compliant factories, follow the process windows provided by the licensor, and ensure approved contract manufacturers comply with the same requirements.\\\", \\\"quality_control\\\": \\\"The licensee shall conduct quality control according to the inspection methods in Appendix B; the licensor may conduct one quality audit per year; non-conforming products may not be sold.\\\", \\\"sales_obligations\\\": \\\"The licensee shall commercialize in the stationary energy storage market and submit quarterly sales reports.\\\", \\\"marking_and_notice\\\": \\\"Licensed product labels must indicate licensed patent numbers such as CN209876543A and CN214567890B.\\\", \\\"minimum_commitments\\\": \\\"From the second full year after effectiveness, annual sales shall be no less than 20,000 battery packs; if not met without force majeure, the licensor may convert the exclusive license to a non-exclusive license.\\\"}\", \"technical_material_delivery\": \"{\\\"materials\\\": [\\\"Coating formulations and raw material specifications\\\", \\\"Slurry preparation parameters\\\", \\\"Process flow diagrams\\\", \\\"Quality inspection methods\\\", \\\"Trial samples\\\", \\\"Test reports\\\"], \\\"delivery_deadline\\\": \\\"First batch of materials delivered within 30 days after the agreement takes effect; two remote technical training sessions provided before the licensee's first pilot test.\\\", \\\"delivery_format\\\": \\\"Chinese electronic files delivered via encrypted download links.\\\", \\\"acceptance_and_support\\\": \\\"The licensee shall accept within 15 days after receiving the materials; materials that do not meet Appendix B indicators shall be remedied by the licensor within 10 working days, and two remote training sessions shall be provided.\\\", \\\"confidentiality_requirements\\\": \\\"Materials may be accessed only by the licensee and employees and consultants bound by confidentiality obligations, and may not be copied, disclosed, or used outside the licensed field without the licensor's written consent.\\\"}\", \"infringement_and_enforcement\": \"{\\\"infringement_notification\\\": \\\"Upon discovering or reasonably suspecting third-party infringement, the discovering party shall notify the other party within 10 days and provide infringement evidence.\\\", \\\"enforcement_rights\\\": \\\"The licensor has the right to decide whether to initiate administrative or civil enforcement; if the licensor does not act, the licensee may bring an action with the licensor's written consent.\\\", \\\"cost_and_recovery\\\": \\\"When the licensor leads the case, it bears the lead litigation costs and receives 60% of damages, and the licensee bears the remaining costs and receives 40%; specific costs are based on actual case expenditures.\\\", \\\"cooperation\\\": \\\"The parties shall provide reasonable assistance such as patent documents, product samples, technical personnel, and testimony, and grant each other necessary litigation authorization.\\\", \\\"settlement_control\\\": \\\"Neither party may, without the other party's written consent, enter into a settlement that acknowledges patent invalidity, acknowledges infringement liability, or materially affects the other party's rights.\\\"}\", \"field_and_territory_restrictions\": \"{\\\"application_fields\\\": [\\\"Stationary energy storage batteries\\\", \\\"Stationary energy storage battery packs\\\"], \\\"territories\\\": [\\\"Mainland China\\\"], \\\"customer_restrictions\\\": \\\"May not provide licensed products to military customers or customers using the products for military purposes.\\\", \\\"channel_restrictions\\\": \\\"No specific distribution platform restrictions are stipulated, but sales must be limited to Mainland China and comply with export and sanctions compliance requirements.\\\", \\\"exclusivity\\\": \\\"Exclusive within the stationary energy storage field and Mainland China; the licensor reserves excluded fields and excluded territories.\\\"}\"}","[{\"party_name\": \"Chengming Energy Research Institute\", \"party_role\": \"Licensor\", \"entity_type\": \"Research Institution\", \"jurisdiction\": \"Mainland China\"}, {\"party_name\": \"Yuancen Energy Storage Technology Co., Ltd.\", \"party_role\": \"Licensee\", \"entity_type\": \"Company\", \"jurisdiction\": \"Mainland China\"}]","Patent and Technology License Agreement\nLicensor: Chengming Energy Research Institute; Licensee: Yuancen Energy Storage Technology Co., Ltd.\nArticle 1 Licensed Technology. The licensed patents include patents and patent applications owned or controlled by the licensor relating to manganese-based cathode surface coatings for aqueous zinc-ion batteries, specifically including CN209876543A, CN214567890B, and their family applications within the licensed territory. The licensed technology also includes the coating formulations, slurry preparation parameters, and heat treatment processes listed in Appendix A.\nArticle 2 Delivery of Materials. The licensor shall, within 30 days after the agreement takes effect, deliver the coating formulations, process flow diagrams, quality inspection methods, trial samples, and test reports, and shall provide two remote technical training sessions before the licensee's first pilot test. The materials shall be delivered as Chinese electronic files and encrypted download links. The licensee shall complete acceptance within 15 days after receipt; if the materials do not meet the indicators in Appendix B, the licensor shall remedy them within 10 working days.\nArticle 3 Licensed Rights. The licensor grants the licensee an exclusive license to manufacture, use, offer for sale, sell, and import licensed products in Mainland China, but only for stationary energy storage batteries and their battery packs. The licensee may not sublicense the licensed technology to third parties, but may entrust manufacturing to contract manufacturers approved in writing by the licensor. The licensor reserves rights for research, teaching, and non-commercial testing.\nArticle 4 Field and Territory. The licensed field is stationary energy storage, excluding new energy vehicles, consumer electronics, and military uses; the licensed territory is Mainland China, excluding Hong Kong, Macao, and Taiwan. The licensor shall not grant the same exclusive rights to third parties in the licensed field, but reserves the right to practice or license in the excluded fields.\nArticle 5 Manufacturing and Sales. The licensee shall produce licensed products in factories compliant with ISO 9001, follow the process windows provided by the licensor, and accept one quality audit per year. Product labels shall indicate the licensed patent numbers. The licensee shall sell no fewer than 20,000 battery packs in the second full year after effectiveness; if the minimum commitment is not met and no force majeure applies, the licensor may convert the exclusive license into a non-exclusive license.\nArticle 6 Improvements. Technical improvements made by the licensee in coating thickness control and low-temperature cycle performance shall belong to the licensee, but the licensee shall notify the licensor in writing 30 days before filing a patent application or public disclosure and shall grant the licensor a worldwide, non-exclusive, royalty-free license for internal research and non-commercial use. Improvements completed jointly by the parties shall be jointly owned in proportion to contributions.\nArticle 7 Infringement. If either party discovers that a third party infringes the licensed patents, it shall notify the other party within 10 days and provide evidence. The licensor has the right to decide whether to bring an action; if the licensor does not act, the licensee may bring an action after the licensor's written consent. The licensor shall bear the costs of the lead action and receive 60% of damages, and the licensee shall bear the remaining costs and receive 40% of damages. Without the other party's written consent, neither party may enter into a settlement that acknowledges patent invalidity or affects the other party's rights.\nArticle 8 Export Compliance. Without obtaining applicable export licenses, the licensee may not export, re-export, or disclose the licensed technology to destinations restricted by U.S., EU, or Chinese export controls or to entities on sanctions lists. The parties shall comply with export control, customs, and anti-sanctions laws.\nArticle 9 Fees. The licensee shall pay a non-refundable upfront fee of RMB 800,000; and shall pay a 3% royalty on net sales of licensed products in the licensed territory. Sales reports and payments shall be submitted within 30 days after the end of each quarter, and the licensor may audit once per year.\nArticle 10 Confidentiality. The delivered materials shall be accessible only to the licensee and its employees and consultants bound by confidentiality obligations, and may not be copied or disclosed without the licensor's written consent.","{\"improvement_definition\": \"Upgrades, optimizations, and derivative technical improvements to coating thickness control, slurry stability, low-temperature cycle performance, or licensed process parameters.\", \"ownership\": \"Improvements independently completed by the licensee belong to the licensee; improvements jointly completed by the parties are jointly owned in proportion to actual technical contributions.\", \"disclosure_obligation\": \"The licensee shall notify the licensor in writing 30 days before filing a patent application or disclosing improvements and provide a technical summary sufficient for evaluation.\", \"license_back\": \"The licensee grants the licensor a worldwide, non-exclusive, royalty-free license for internal research and non-commercial use.\", \"invention_assignment\": \"Improvements jointly completed by the parties shall be jointly patented in proportion to shared ownership; neither party may separately assign its shared share without the other party's consent.\"}","Patent and Technology License Agreement","{\"controlled_destinations\": [\"Destinations subject to U.S. export control restrictions\", \"Destinations subject to EU sanctions or export control restrictions\", \"Destinations subject to Chinese export control restrictions\", \"Entities on applicable sanctions lists\"], \"compliance_obligations\": \"The parties shall comply with applicable export control, customs, sanctions, and anti-sanctions laws, and may not circumvent technology export restrictions through third parties.\", \"required_approvals\": \"Before exporting, re-exporting, or disclosing licensed technology abroad, applicable government export licenses and internal compliance approvals of both parties shall be obtained.\", \"prohibited_transactions\": \"It is prohibited to export, re-export, or disclose licensed technology to controlled destinations or sanctioned entities, and to conduct cross-border technology transfers without approval.\"}","[{\"clause_topic\": \"Scope of licensed patents\", \"quote\": \"The licensed patents include patents and patent applications owned or controlled by the licensor relating to manganese-based cathode surface coatings for aqueous zinc-ion batteries, specifically including CN209876543A, CN214567890B, and their family applications within the licensed territory.\", \"source_location\": \"Article 1 Licensed Technology\", \"relevance\": \"Defines the licensed patents, patent identifiers, and family application scope, applicable for searching the objects covered by the licensed technology.\"}, {\"clause_topic\": \"Manufacturing and sales rights\", \"quote\": \"The licensor grants the licensee an exclusive license to manufacture, use, offer for sale, sell, and import licensed products in Mainland China, but only for stationary energy storage batteries and their battery packs.\", \"source_location\": \"Article 3 Licensed Rights\", \"relevance\": \"Directly states the license nature, commercialization rights, territory, and application field restrictions.\"}, {\"clause_topic\": \"Minimum commercialization commitment\", \"quote\": \"The licensee shall sell no fewer than 20,000 battery packs in the second full year after effectiveness; if the minimum commitment is not met and no force majeure applies, the licensor may convert the exclusive license into a non-exclusive license.\", \"source_location\": \"Article 5 Manufacturing and Sales\", \"relevance\": \"Reflects the minimum sales volume and change in exclusivity if not met, and is important evidence for commercialization obligation searches.\"}, {\"clause_topic\": \"Improvement technology\", \"quote\": \"Technical improvements made by the licensee in coating thickness control and low-temperature cycle performance shall belong to the licensee, but the licensee shall notify the licensor in writing 30 days before filing a patent application or public disclosure and shall grant the licensor a worldwide, non-exclusive, royalty-free license for internal research and non-commercial use.\", \"source_location\": \"Article 6 Improvements\", \"relevance\": \"Supports structured conclusions on ownership of improvements, disclosure deadline, and royalty-free grant-back license.\"}, {\"clause_topic\": \"Export restrictions\", \"quote\": \"Without obtaining applicable export licenses, the licensee may not export, re-export, or disclose the licensed technology to destinations restricted by U.S., EU, or Chinese export controls or to entities on sanctions lists.\", \"source_location\": \"Article 8 Export Compliance\", \"relevance\": \"Clarifies controlled destinations, approval requirements, and prohibited cross-border technology transactions.\"}]","{\"royalty_basis\": \"Net sales of licensed products in Mainland China, i.e., actual sales revenue after deducting discounts, returns, VAT, and freight.\", \"royalty_rate\": \"In addition to the upfront fee, a 3% royalty on net sales.\", \"milestone_or_lump_sum\": \"A non-refundable upfront fee of RMB 800,000 payable after the agreement takes effect; no additional milestone payments are stipulated.\", \"reporting_and_audit\": \"Sales reports and royalty payments shall be submitted within 30 days after the end of each quarter; the licensor may audit relevant books once per year, and if underreporting exceeds 5%, the licensee shall bear audit costs.\", \"payment_timing\": \"Reports and payments shall be completed within 30 days after the end of each quarter; overdue payments shall bear default interest as stipulated in the agreement.\"}","[{\"obligor\": \"Chengming Energy Research Institute\", \"obligation\": \"Deliver formulations, process documents, samples, and test reports, and provide two remote technical training sessions.\", \"deadline\": \"Within 30 days after the agreement takes effect; training completed before the first pilot test.\", \"trigger\": \"Agreement effectiveness and the licensee's first pilot test.\", \"consequence\": \"If materials are not delivered as required or are defective, the licensee may require remediation within 10 working days.\"}, {\"obligor\": \"Yuancen Energy Storage Technology Co., Ltd.\", \"obligation\": \"Manufacture and sell licensed products in the stationary energy storage field in Mainland China and comply with process and quality requirements.\", \"deadline\": \"Continuous performance during the agreement term.\", \"trigger\": \"Obtaining the license and starting pilot or commercial production.\", \"consequence\": \"Serious violation of field, territory, or quality restrictions may constitute breach and lead to termination of the license.\"}, {\"obligor\": \"Yuancen Energy Storage Technology Co., Ltd.\", \"obligation\": \"Sell no fewer than 20,000 battery packs per year starting from the second full year.\", \"deadline\": \"Verified at the end of each full year.\", \"trigger\": \"Entering the second full year after the agreement takes effect.\", \"consequence\": \"If not met without force majeure, the licensor may convert the exclusive license to a non-exclusive license.\"}, {\"obligor\": \"Both parties\", \"obligation\": \"Promptly notify, provide evidence, and cooperate in enforcement upon discovering third-party infringement.\", \"deadline\": \"Notify within 10 days after discovering infringement.\", \"trigger\": \"Discovery or reasonable suspicion of third-party infringement.\", \"consequence\": \"If delayed notice expands losses, the breaching party shall bear corresponding liability.\"}, {\"obligor\": \"Yuancen Energy Storage Technology Co., Ltd.\", \"obligation\": \"Obtain applicable approvals and comply with export controls before exporting, re-exporting, or disclosing technology.\", \"deadline\": \"Before the relevant cross-border activity occurs.\", \"trigger\": \"Intended transfer of technology or products abroad.\", \"consequence\": \"Transactions without approval constitute material breach, and the licensor may suspend materials and licensed rights.\"}]","{\"grant_type\": \"Exclusive License\", \"manufacturing_rights\": \"The licensee may manufacture stationary energy storage batteries and battery packs in Mainland China, and may entrust manufacturing to contract manufacturers approved in writing by the licensor.\", \"use_rights\": \"May use the licensed technology in the stationary energy storage field for R&D, pilot testing, production, and non-export commercial applications.\", \"sales_rights\": \"May offer for sale, sell, and distribute licensed products in Mainland China, but may not sell or use them in excluded fields.\", \"sublicensing_rights\": \"In principle, no sublicensing; manufacturing may only be entrusted to contract manufacturers approved in writing by the licensor and subject to equivalent confidentiality obligations.\", \"reservation_of_rights\": \"The licensor reserves research, teaching, non-commercial testing, and the right to practice or license in excluded fields such as new energy vehicles, consumer electronics, and military.\"}","This is an exclusive license granted by Chengming Energy Research Institute to Yuancen Energy Storage Technology Co., Ltd. for stationary energy storage battery coating technology in Mainland China. The license scope covers two patents and their family applications and includes formulations, processes, and testing materials; the licensee obtains rights to manufacture, use, sell, and import, but may not use the technology in new energy vehicles, consumer electronics, or military fields, and may not sublicense without consent. The agreement sets conditions for material delivery, quality audits, minimum sales volume, improvement grant-back, infringement cooperation, export control, and royalties calculated on net sales.","[\"aqueous zinc-ion battery patent license\", \"manganese-based cathode coating technology\", \"stationary energy storage exclusive license\", \"Mainland China licensed territory\", \"minimum sales volume of licensed products\", \"technical material delivery and acceptance\", \"royalty-free grant-back of improvements\", \"allocation of third-party infringement litigation costs\", \"licensed patent marking\", \"export control and re-export\", \"3% royalty on net sales\"]","{\"scope_definition\": \"The licensed patents include patents, patent applications, and family applications within the licensed territory owned or controlled by the licensor relating to manganese-based cathode surface coatings for aqueous zinc-ion batteries, and extend to the formulations, slurry preparation parameters, and heat treatment processes listed in Appendix A.\", \"patent_identifiers\": [\"CN209876543A\", \"CN214567890B\", \"family applications within the licensed territory\"], \"covered_technology\": \"Manganese-based cathode surface coatings for aqueous zinc-ion batteries, coating slurry preparation, heat treatment processes, and their application in stationary energy storage batteries.\", \"included_rights\": \"Includes the right to practice by manufacturing, using, offering for sale, selling, and importing licensed products within the licensed territory and licensed field, and the right to use related technical materials for pilot testing and commercial production.\", \"exclusions\": \"Excludes new energy vehicles, consumer electronics, and military uses; excludes Hong Kong, Macao, and Taiwan; no sublicensing to third parties without the licensor's written consent.\", \"status_and_maintenance\": \"The licensor is responsible for maintaining the licensed patents and paying ordinary annual fees; if it intends to abandon or cease maintaining any licensed patent, it shall notify the licensee at least 60 days in advance, and the licensee may choose to maintain the relevant rights itself.\"}","{\"manufacturing_obligations\": \"The licensee shall manufacture in ISO 9001-compliant factories, follow the process windows provided by the licensor, and ensure approved contract manufacturers comply with the same requirements.\", \"quality_control\": \"The licensee shall conduct quality control according to the inspection methods in Appendix B; the licensor may conduct one quality audit per year; non-conforming products may not be sold.\", \"sales_obligations\": \"The licensee shall commercialize in the stationary energy storage market and submit quarterly sales reports.\", \"marking_and_notice\": \"Licensed product labels must indicate licensed patent numbers such as CN209876543A and CN214567890B.\", \"minimum_commitments\": \"From the second full year after effectiveness, annual sales shall be no less than 20,000 battery packs; if not met without force majeure, the licensor may convert the exclusive license to a non-exclusive license.\"}","{\"materials\": [\"Coating formulations and raw material specifications\", \"Slurry preparation parameters\", \"Process flow diagrams\", \"Quality inspection methods\", \"Trial samples\", \"Test reports\"], \"delivery_deadline\": \"First batch of materials delivered within 30 days after the agreement takes effect; two remote technical training sessions provided before the licensee's first pilot test.\", \"delivery_format\": \"Chinese electronic files delivered via encrypted download links.\", \"acceptance_and_support\": \"The licensee shall accept within 15 days after receiving the materials; materials that do not meet Appendix B indicators shall be remedied by the licensor within 10 working days, and two remote training sessions shall be provided.\", \"confidentiality_requirements\": \"Materials may be accessed only by the licensee and employees and consultants bound by confidentiality obligations, and may not be copied, disclosed, or used outside the licensed field without the licensor's written consent.\"}","{\"infringement_notification\": \"Upon discovering or reasonably suspecting third-party infringement, the discovering party shall notify the other party within 10 days and provide infringement evidence.\", \"enforcement_rights\": \"The licensor has the right to decide whether to initiate administrative or civil enforcement; if the licensor does not act, the licensee may bring an action with the licensor's written consent.\", \"cost_and_recovery\": \"When the licensor leads the case, it bears the lead litigation costs and receives 60% of damages, and the licensee bears the remaining costs and receives 40%; specific costs are based on actual case expenditures.\", \"cooperation\": \"The parties shall provide reasonable assistance such as patent documents, product samples, technical personnel, and testimony, and grant each other necessary litigation authorization.\", \"settlement_control\": \"Neither party may, without the other party's written consent, enter into a settlement that acknowledges patent invalidity, acknowledges infringement liability, or materially affects the other party's rights.\"}","{\"application_fields\": [\"Stationary energy storage batteries\", \"Stationary energy storage battery packs\"], \"territories\": [\"Mainland China\"], \"customer_restrictions\": \"May not provide licensed products to military customers or customers using the products for military purposes.\", \"channel_restrictions\": \"No specific distribution platform restrictions are stipulated, but sales must be limited to Mainland China and comply with export and sanctions compliance requirements.\", \"exclusivity\": \"Exclusive within the stationary energy storage field and Mainland China; the licensor reserves excluded fields and excluded territories.\"}","{\"parties\":\"[{\\\"party_name\\\": \\\"Yaochen Optoelectronics Technology Co., Ltd.\\\", \\\"party_role\\\": \\\"Licensor\\\", \\\"entity_type\\\": \\\"Company\\\", \\\"jurisdiction\\\": \\\"Mainland China\\\"}, {\\\"party_name\\\": \\\"Hengchuan Manufacturing Group Co., Ltd.\\\", \\\"party_role\\\": \\\"Licensee\\\", \\\"entity_type\\\": \\\"Company\\\", \\\"jurisdiction\\\": \\\"Mainland China\\\"}]\",\"source_text\":\"Non-exclusive Patent License Agreement for Photovoltaic Module Encapsulation Technology\\nLicensor: Yaochen Optoelectronics Technology Co., Ltd.; Licensee: Hengchuan Manufacturing Group Co., Ltd.\\nArticle 1 Licensed Patents. The licensed patents include the licensor's Chinese patents CN216789012B and CN218901234A relating to high-barrier flexible photovoltaic module encapsulation films, edge sealing structures, and online defect detection methods, and granted patents derived from the priority of the above patents within the licensed territory. The scope does not include organic photovoltaic devices or core material formulations for perovskite cells not listed by the licensor.\\nArticle 2 Technical Materials. The licensor shall, within 20 working days after the first license fee is received, deliver the encapsulation film lamination temperature window, equipment calibration specifications, detection algorithm interface specifications, three sets of test samples, and a quality control checklist. Materials shall be transmitted through encrypted files, and English equipment interface documents shall be accompanied by Chinese summaries. The licensee shall raise objections within 10 working days, and the licensor shall provide 90 days of remote debugging support.\\nArticle 3 Rights. The licensor grants the licensee a non-exclusive license to manufacture, use, sell, offer for sale, and import licensed products in Japan, Germany, and Vietnam. The licensee may use approved suppliers for its own production purposes, but may not grant sublicenses or assign patent practice rights to third parties. The licensor and its existing customers may continue to practice and license the licensed patents worldwide.\\nArticle 4 Field, Customers, and Channels. Licensed products are limited to crystalline silicon photovoltaic module encapsulation films and module edge sealing systems and may not be used in aerospace, military optoelectronics, or medical implant devices. The licensee may not sell through unregistered distributors and may not supply sanctioned entities. Direct sales are permitted in the Japanese market, while the German and Vietnamese markets must be served through the licensee's own sales entities.\\nArticle 5 Manufacturing and Commercialization. The licensee shall manufacture in factories certified to ISO 14001, use key raw materials approved by the licensor, and accept one quality audit per year by the licensor. Products shall be marked with a patent license notice and batch traceability code. The licensee shall complete first article certification within 12 months after the agreement takes effect and achieve net sales of no less than RMB 150 million in the second year; if the target is not met, the licensor may require a rectification plan, but the license nature will not automatically change.\\nArticle 6 Improvements. Equipment adaptations, online detection parameters, and encapsulation process improvements independently developed by the licensee belong to the licensee. For improvements involving claims of the licensed patents, the licensee shall notify the licensor 45 days before filing and grant the licensor a non-exclusive license within the licensor's existing photovoltaic product lines. The licensor is not obligated to automatically license its improvements to the licensee, but the parties may separately sign license documents.\\nArticle 7 Infringement Handling. Upon discovering third-party infringement, the discovering party shall notify within 7 days. Either party may take enforcement action in the market where it is directly harmed, but shall notify the other party 30 days in advance; the other party shall provide reasonable assistance. Enforcement costs shall be borne by the initiating party, and net damages obtained shall belong to the initiating party; cases involving a common market of both parties shall be decided through consultation. Settlements may not include acknowledgment or waiver of the validity of the licensed patents.\\nArticle 8 Export Restrictions. The parties shall comply with export control, customs, and sanctions regulations of Japan, Germany, Vietnam, and the actual places of export of goods and technology. Without necessary government licenses, the encapsulation film formulations, detection algorithm interfaces, or production parameters may not be re-exported to controlled destinations.\\nArticle 9 Fees and Audit. The licensee shall pay an initial license fee of RMB 2 million and tiered royalties on net sales: 2% for annual net sales up to RMB 50 million and 3% for the excess. Reports and payments shall be submitted within 40 days after the end of each quarter, and the licensor may audit once per year.\",\"improvements\":\"{\\\"improvement_definition\\\": \\\"Optimization, upgrades, or derivative development of equipment adaptation, online detection parameters, lamination processes, and edge sealing processes.\\\", \\\"ownership\\\": \\\"Equipment adaptations, detection parameters, and encapsulation process improvements independently developed by the licensee belong to the licensee.\\\", \\\"disclosure_obligation\\\": \\\"For improvements involving claims of the licensed patents, the licensee shall notify the licensor 45 days before filing a patent application.\\\", \\\"license_back\\\": \\\"The licensee grants the licensor a non-exclusive license to use the relevant improvements within the licensor's existing photovoltaic product lines.\\\", \\\"invention_assignment\\\": \\\"No automatic assignment of invention rights occurs between the parties; if joint filing or cross-licensing is needed, the parties shall sign separate written documents.\\\"}\",\"document_type\":\"Non-exclusive Patent License Agreement\",\"export_control\":\"{\\\"controlled_destinations\\\": [\\\"Controlled destinations under applicable Japanese export controls\\\", \\\"Controlled destinations under applicable German or EU export controls\\\", \\\"Controlled destinations under applicable Vietnamese trade restrictions\\\", \\\"Entities on sanctions lists in each jurisdiction\\\"], \\\"compliance_obligations\\\": \\\"The parties shall comply with export control, customs, sanctions, and re-export laws of the actual places of export of products and technology, and shall manage classification of formulations, algorithm interfaces, and production parameters.\\\", \\\"required_approvals\\\": \\\"Before exporting or re-exporting to controlled destinations, relevant government export licenses, customs approvals, and internal compliance approvals shall be obtained.\\\", \\\"prohibited_transactions\\\": \\\"It is prohibited to re-export encapsulation film formulations, detection algorithm interfaces, and production parameters to controlled destinations without approval, and to supply sanctioned entities.\\\"}\",\"clause_evidence\":\"[{\\\"clause_topic\\\": \\\"Scope of licensed patents\\\", \\\"quote\\\": \\\"The licensed patents include the licensor's Chinese patents CN216789012B and CN218901234A relating to high-barrier flexible photovoltaic module encapsulation films, edge sealing structures, and online defect detection methods.\\\", \\\"source_location\\\": \\\"Article 1 Licensed Patents\\\", \\\"relevance\\\": \\\"Lists the licensed patent identifiers and corresponding encapsulation and detection technology subject matter.\\\"}, {\\\"clause_topic\\\": \\\"Non-exclusive license rights\\\", \\\"quote\\\": \\\"The licensor grants the licensee a non-exclusive license to manufacture, use, sell, offer for sale, and import licensed products in Japan, Germany, and Vietnam.\\\", \\\"source_location\\\": \\\"Article 3 Rights\\\", \\\"relevance\\\": \\\"Clarifies the license nature, territory, and commercialization rights such as manufacturing and sales.\\\"}, {\\\"clause_topic\\\": \\\"Channel and customer restrictions\\\", \\\"quote\\\": \\\"The licensee may not sell through unregistered distributors and may not supply sanctioned entities.\\\", \\\"source_location\\\": \\\"Article 4 Field, Customers, and Channels\\\", \\\"relevance\\\": \\\"Supports structured extraction of sales channel and customer compliance restrictions.\\\"}, {\\\"clause_topic\\\": \\\"Improvement grant-back license\\\", \\\"quote\\\": \\\"For improvements involving claims of the licensed patents, the licensee shall notify the licensor 45 days before filing and grant the licensor a non-exclusive license within the licensor's existing photovoltaic product lines.\\\", \\\"source_location\\\": \\\"Article 6 Improvements\\\", \\\"relevance\\\": \\\"States the improvement notice period, improvement scope, and limited grant-back license.\\\"}, {\\\"clause_topic\\\": \\\"Tiered royalties\\\", \\\"quote\\\": \\\"Tiered royalties on net sales: 2% for annual net sales up to RMB 50 million and 3% for the excess.\\\", \\\"source_location\\\": \\\"Article 9 Fees and Audit\\\", \\\"relevance\\\": \\\"Clarifies the royalty calculation basis and tiered rates, applicable to economic term searches.\\\"}]\",\"financial_terms\":\"{\\\"royalty_basis\\\": \\\"Net sales of licensed products in the licensed territory, calculated on cumulative annual net sales.\\\", \\\"royalty_rate\\\": \\\"2% for the portion of annual net sales up to RMB 50 million and 3% for the excess.\\\", \\\"milestone_or_lump_sum\\\": \\\"An initial license fee of RMB 2 million payable after the agreement takes effect and payment conditions are met; no additional milestone payments are stipulated.\\\", \\\"reporting_and_audit\\\": \\\"Sales reports submitted within 40 days after the end of each quarter; the licensor may audit sales, production, and distribution records once per year.\\\", \\\"payment_timing\\\": \\\"Reports and royalty payments completed within 40 days after the end of each quarter; if an audit finds underreporting, the difference shall be paid after notice.\\\"}\",\"key_obligations\":\"[{\\\"obligor\\\": \\\"Yaochen Optoelectronics Technology Co., Ltd.\\\", \\\"obligation\\\": \\\"Deliver encapsulation process, equipment calibration, detection interface, and quality control materials, and provide remote debugging support.\\\", \\\"deadline\\\": \\\"Delivered within 20 working days after the initial license fee is received; support provided within 90 days after delivery.\\\", \\\"trigger\\\": \\\"Receipt of the initial license fee.\\\", \\\"consequence\\\": \\\"If materials are delayed or materially defective, the licensee may raise objections and require remediation, and the relevant support period shall be extended accordingly.\\\"}, {\\\"obligor\\\": \\\"Hengchuan Manufacturing Group Co., Ltd.\\\", \\\"obligation\\\": \\\"Manufacture at certified factories using approved raw materials and processes, and accept quality audits.\\\", \\\"deadline\\\": \\\"Continuous performance during the agreement term.\\\", \\\"trigger\\\": \\\"Starting production of licensed products.\\\", \\\"consequence\\\": \\\"Serious violation of quality requirements or refusal of audits may constitute material breach and lead to suspension of the license.\\\"}, {\\\"obligor\\\": \\\"Hengchuan Manufacturing Group Co., Ltd.\\\", \\\"obligation\\\": \\\"Complete first article certification and achieve net sales of no less than RMB 150 million in the second year.\\\", \\\"deadline\\\": \\\"First article certification completed within 12 months after the agreement takes effect; sales target verified in the second year.\\\", \\\"trigger\\\": \\\"Agreement effectiveness and commencement of commercial production.\\\", \\\"consequence\\\": \\\"If the sales target is not met, submit a rectification plan, but the non-exclusive license is not automatically changed to another license type.\\\"}, {\\\"obligor\\\": \\\"Hengchuan Manufacturing Group Co., Ltd.\\\", \\\"obligation\\\": \\\"Pay tiered royalties and submit quarterly sales reports.\\\", \\\"deadline\\\": \\\"Within 40 days after the end of each quarter.\\\", \\\"trigger\\\": \\\"Sales of licensed products occur.\\\", \\\"consequence\\\": \\\"For late reporting or underreporting, the licensor may audit and require payment of the difference and applicable interest.\\\"}, {\\\"obligor\\\": \\\"Both parties\\\", \\\"obligation\\\": \\\"Comply with export control, sanctions, and re-export restrictions and not transfer technology or products to controlled entities.\\\", \\\"deadline\\\": \\\"Before each export, re-export, or supply.\\\", \\\"trigger\\\": \\\"Cross-border transfer or sale to overseas customers occurs.\\\", \\\"consequence\\\": \\\"Violation of restrictions may lead to suspension of transactions, suspension or termination of the license, and compliance liability borne by the responsible party.\\\"}]\",\"licensed_rights\":\"{\\\"grant_type\\\": \\\"Non-exclusive License\\\", \\\"manufacturing_rights\\\": \\\"The licensee may manufacture licensed products within the licensed territory and may use suppliers approved by the licensor for its own production purposes.\\\", \\\"use_rights\\\": \\\"May use the encapsulation film, edge sealing, and detection technologies in the crystalline silicon photovoltaic module encapsulation field for production and quality control.\\\", \\\"sales_rights\\\": \\\"May offer for sale, sell, and import licensed products in Japan, Germany, and Vietnam, subject to customer, channel, sanctions, and territory requirements.\\\", \\\"sublicensing_rights\\\": \\\"May not grant sublicenses or assign patent practice rights to third parties; use of approved suppliers does not constitute sublicensing.\\\", \\\"reservation_of_rights\\\": \\\"The licensor and its existing customers reserve all rights not granted to practice and license the licensed patents worldwide.\\\"}\",\"document_summary\":\"This is a non-exclusive license granted by Yaochen Optoelectronics Technology Co., Ltd. to Hengchuan Manufacturing Group Co., Ltd. for photovoltaic module encapsulation technology. The license covers high-barrier flexible encapsulation films, edge sealing structures, and online defect detection patents and permits the licensee to manufacture, use, sell, and import crystalline silicon photovoltaic module encapsulation products in Japan, Germany, and Vietnam. The agreement restricts application fields, distributors, and sanctioned customers, and provides for material delivery, quality audits, first article certification, sales targets, improvement notices and license grant-back, tiered royalties, and export compliance obligations.\",\"retrieval_keywords\":\"[\\\"photovoltaic module encapsulation patent license\\\", \\\"high-barrier flexible encapsulation film\\\", \\\"non-exclusive edge sealing technology license\\\", \\\"online defect detection algorithm\\\", \\\"Japan Germany Vietnam licensed territory\\\", \\\"patent marking for licensed photovoltaic products\\\", \\\"first article certification and sales target\\\", \\\"tiered royalty rates\\\", \\\"grant-back license for improvements\\\", \\\"distributor channel restrictions\\\", \\\"photovoltaic technology export control\\\"]\",\"licensed_patent_scope\":\"{\\\"scope_definition\\\": \\\"The licensed patents include the listed Chinese patents relating to high-barrier flexible photovoltaic module encapsulation films, edge sealing structures, and online defect detection methods, and patents derived from their priority and granted within the licensed territory.\\\", \\\"patent_identifiers\\\": [\\\"CN216789012B\\\", \\\"CN218901234A\\\", \\\"granted patents in the licensed territory derived from the priority of the above patents\\\"], \\\"covered_technology\\\": \\\"Crystalline silicon photovoltaic module encapsulation films, module edge sealing structures, lamination processes, and online defect detection methods.\\\", \\\"included_rights\\\": \\\"Non-exclusive patent practice rights to manufacture, use, offer for sale, sell, and import licensed products in Japan, Germany, and Vietnam, and the right to use related technical materials for the licensee's own production.\\\", \\\"exclusions\\\": \\\"Excludes organic photovoltaic devices, core material formulations for perovskite cells, and aerospace, military optoelectronics, and medical implant device uses.\\\", \\\"status_and_maintenance\\\": \\\"The licensor is responsible for annuity fees and maintenance of the licensed patents and shall promptly notify the licensee of patent invalidation, abandonment, or material changes in claim scope.\\\"}\",\"manufacturing_sales_terms\":\"{\\\"manufacturing_obligations\\\": \\\"The licensee shall manufacture in factories certified to ISO 14001 and use key raw materials and process parameters approved by the licensor.\\\", \\\"quality_control\\\": \\\"The licensee shall inspect according to the quality control checklist; the licensor may conduct one quality audit per year; products shall have batch traceability records.\\\", \\\"sales_obligations\\\": \\\"The licensee shall complete first article certification and conduct sales development within the licensed territory, and submit quarterly sales reports.\\\", \\\"marking_and_notice\\\": \\\"Products must be marked with a patent license notice and batch traceability code, and promotional materials may not imply exclusivity.\\\", \\\"minimum_commitments\\\": \\\"Complete first article certification within 12 months after the agreement takes effect; second-year net sales target of no less than RMB 150 million; if not met, submit a rectification plan but the license nature does not automatically change.\\\"}\",\"technical_material_delivery\":\"{\\\"materials\\\": [\\\"Encapsulation film lamination temperature window\\\", \\\"Equipment calibration specifications\\\", \\\"Online defect detection algorithm interface specifications\\\", \\\"Three sets of test samples\\\", \\\"Quality control checklist\\\"], \\\"delivery_deadline\\\": \\\"Delivered within 20 working days after the initial license fee is received; 90 days of remote debugging support provided after delivery.\\\", \\\"delivery_format\\\": \\\"Transmitted through encrypted files; English equipment interface documents accompanied by Chinese summaries.\\\", \\\"acceptance_and_support\\\": \\\"The licensee shall raise material objections within 10 working days; the licensor shall provide 90 days of remote debugging and interface adaptation support.\\\", \\\"confidentiality_requirements\\\": \\\"Materials may be used only by the licensee's internal production, quality, and R&D personnel and may not be copied, disclosed, or transferred to unregistered distributors or other third parties.\\\"}\",\"infringement_and_enforcement\":\"{\\\"infringement_notification\\\": \\\"Upon discovering third-party infringement, the discovering party shall notify the other party within 7 days and provide available infringement evidence.\\\", \\\"enforcement_rights\\\": \\\"Either party may take administrative or civil enforcement action in the market where it is directly harmed, but shall notify the other party 30 days in advance; cases involving a common market of both parties shall be decided through consultation.\\\", \\\"cost_and_recovery\\\": \\\"Enforcement costs are borne by the initiating party, and net damages obtained belong to the initiating party; costs and proceeds in common market cases shall be separately negotiated.\\\", \\\"cooperation\\\": \\\"The other party shall provide patent documents, product samples, technical opinions, and necessary witness assistance, but reasonable external costs shall be borne by the initiating party.\\\", \\\"settlement_control\\\": \\\"Settlements may not include acknowledgment or waiver of the validity of the licensed patents or restrict the other party from continuing to practice the licensed rights.\\\"}\",\"field_and_territory_restrictions\":\"{\\\"application_fields\\\": [\\\"Crystalline silicon photovoltaic module encapsulation films\\\", \\\"Crystalline silicon photovoltaic module edge sealing systems\\\", \\\"Online defect detection for photovoltaic modules\\\"], \\\"territories\\\": [\\\"Japan\\\", \\\"Germany\\\", \\\"Vietnam\\\"], \\\"customer_restrictions\\\": \\\"May not supply sanctioned entities or customers intending to use the products in aerospace, military optoelectronics, or medical implant devices.\\\", \\\"channel_restrictions\\\": \\\"May not sell through unregistered distributors; direct sales are permitted in Japan, while Germany and Vietnam must be served through the licensee's own sales entities.\\\", \\\"exclusivity\\\": \\\"Non-exclusive license; the licensor and existing customers may continue to practice or license the licensed patents, with no market exclusivity.\\\"}\"}","MOBIUSI INC","https:\u002F\u002Fstatic.mobiusi.com\u002Fmobiwusi\u002F20250829\u002F7bf4ac62b4533e2b809998a6f1c5491e.png?Expires=1792463130&OSSAccessKeyId=LTAI5tH8MQqhgeiAtrzCHrxM&Signature=v6Tr8jBrdm4s5wU1SnnyGsYg%2Bhw%3D&x-oss-process=image%2Fresize%2Cm_fill%2Cw_35%2Ch_35",[758,764],{"type":759,"title":760,"count_data":761},"bar","Length distribution",[762],{"name":763,"value":483},"1k lower",{"type":765,"title":766,"count_data":767},"pie","Language distribution",[768],{"name":769,"value":483},"English"]